scieee Open visual document viewer

Biological implications of differential expression of mitochondrial-shaping proteins in Parkinson’s disease

Rocha, S,Freitas, A,Guimarães, SC,Vitorino, R,Aroso, M,Gomez-Lazaro, M

Abstract

This work was financed by FEDER—Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT—Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Inovação in the framework of the projects “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274), iBiMED (UID/BIM/04501/2013) and UnIC (UID/IC/00051/2013) research units, the COST ACTION CA15203, and the Investigator Grant to Rui Vitorino (IF/00286/2015). Ana Freitas acknowledges FCT for her Ph.D. scholarship (SFRH/BD/111423/2015), as does Sofia C. Guimaraes (SFRH/BPD/122920/2016), and Miguel Aroso (SFRH/BPD/123261/2016). Sara Rocha was founded by the project Norte-01-0145-FEDER-000008 -Porto Neurosciences and Neurologic Disease Research Initiative at I3S, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (FEDER)”.

Full text

an ioxidan s A icle Biological Implica ions o Di e en ial Exp ession o Mi ochond ial-Shaping P o eins in Pa kinson’s Disease Sa a Rocha 1,2,†, Ana F ei as 1,3,4,†, So ia C. Guima aes 1,3, Rui Vi o ino 5,6 ID , Miguel A oso 1,3 and Ma ia Gomez-Laza o 1,3,*ID 1i3S—Ins i u o de In es igação e Ino ação em Saúde, Uni e sidade do Po o, 4200-135 Po o, Po ugal; [email p o ec ed] (S.R.); ana [email p o ec ed] (A.F.); [email p o ec ed] (S.C.G.); [email p o ec ed] (M.A.) 2IBMC—Ins i u o de Biologia Molecula e Celula , Uni e sidade do Po o, 4200-135 Po o, Po ugal 3INEB—Ins i u o de Engenha ia Biomédica, Uni e sidade do Po o, 4200-135 Po o, Po ugal 4FMUP—Faculdade de Medicina da Uni e sidade do Po o, 4200-319 Po o, Po ugal 5 iBiMED, Depa men o Medical Sciences, Uni e si y o A ei o, 3810-193 A ei o, Po ugal; [email p o ec ed] 6Unidade de In es igação Ca dio ascula , Depa amen o de Ci u gia e Fisiologia, Uni e sidade do Po o, 4200-319 Po o, Po ugal *Co espondence: [email p o ec ed]; Tel.: +351-220-408-815 † These au ho s con ibu ed equally o his wo k. Recei ed: 28 No embe 2017; Accep ed: 14 Decembe 2017; Published: 21 Decembe 2017 Abs ac : I has long been accep ed ha mi ochond ial unc ion and mo phology is a ec ed in Pa kinson’s disease, and ha mi ochond ial unc ion can be di ec ly ela ed o i s mo phology. So a , mi ochond ial mo phological al e a ions s udies, in he con ex o his neu odegene a i e disease, ha e been pe o med h ough mic oscopic me hodologies. The goal o he p esen wo k is o add ess i he modi ica ions in he mi ochond ial-shaping p o eins occu ing in his diso de ha e implica ions in o he cellula pa hways, which migh cons i u e impo an pa hways o he disease p og ession. To do so, we conduc ed a no el app oach h ough a ho ough explo a ion o he a ailable p o eomics-based s udies in he con ex o Pa kinson’s disease. The analysis p o ided insigh in o he al e ed biological pa hways a ec ed by changes in he exp ession o mi ochond ial-shaping p o eins ia di e en bioin o ma ic ools. Unexpec edly, we obse ed ha he mi ochond ial-shaping p o eins al e ed in he con ex o Pa kinson’s disease a e, in he as majo i y, ela ed o he o ganiza ion o he mi ochond ial c is ae. Con e sely, in he s udies ha ha e eso ed o mic oscopy-based echniques, he mos widely epo ed al e a ion in he con ex o his diso de is mi ochond ia agmen a ion. C is ae memb ane o ganiza ion is pi o al o mi ochond ial ATP p oduc ion, and changes in hei mo phology ha e a di ec impac on he o ganiza ion and unc ion o he oxida i e phospho yla ion (OXPHOS) complexes. To unde s and which biological p ocesses a e a ec ed by he al e a ion o hese p o eins we analyzed he binding pa ne s o he mi ochond ial-shaping p o eins ha we e ound al e ed in Pa kinson’s disease. We showed ha he binding pa ne s all in o se en di e en cellula componen s, which include mi ochond ia, p o easome, and endoplasmic e iculum (ER), amongs o he s. I is no ewo hy ha , by e alua ing he biological p ocess in which hese modi ied p o eins a e in ol ed, we showed ha hey a e ela ed o he p oduc ion and me abolism o ATP, immune esponse, cy oskele on al e a ion, and oxida i e s ess, amongs o he s. In summa y, wi h ou bioin o ma ics app oach using he da a on he modi ied p o eins in Pa kinson’s disease pa ien s, we we e able o ela e he al e a ion o mi ochond ial-shaping p o eins o modi ica ions o c ucial cellula pa hways a ec ed in his disease. Keywo ds: Pa kinson’s disease; p o eomics; bioin o ma ics; biological p ocesses; mi ochond ia An ioxidan s 2018,7, 1; doi:10.3390/an iox7010001 www.mdpi.com/jou nal/an ioxidan s An ioxidan s 2018,7, 1 2 o 45 1. In oduc ion Mi ochond ia a e pi o al o ganelles o se e al cellula unc ions, namely, he p oduc ion o ATP h ough oxida i e phospho yla ion, he egula ion o he K ebs cycle, a y acid me abolism, gluconeogenesis, heme-syn hesis, calcium and edox homeos asis, cell signaling, and he ampli ica ion o apop osis [ 1 ]. They a e highly dynamic o ganelles, as hey can change hei shape in esponse o cellula s imuli by usion and ission p ocesses and by hei mo emen along he cellula cy oskele on [ 2 ]. Al e a ions o mi ochond ia mo phology can signi ican ly in luence se e al unc ions o he cellula me abolism, no only ela ed o ene gy p oduc ion bu also in communica ion wi h he cy osol and he impo and expo o p o eins, lipids, solu es, and me aboli es o e en he cy osol p o ec ion om possible ha m ul e ec s o ce ain mi ochond ial componen s [ 3 ]. Mi ochond ia dynamic p ocesses a e o u mos impo ance o he mi ochond ial g ow h a e, hei edis ibu ion wi hin he cell, and o he main enance o heal hy mi ochond ia and p ope unc ioning hence hei al e a ions a e equen ly associa ed wi h di e en pa hological condi ions [4]. Pa kinson’s disease is a highly debili a ing condi ion, being a common neu odegene a i e disease, and mo e han 10 million people wo ldwide a e a ec ed by his disease [ 5 ]. Cu en ly, i s e iology is no ully un a eled; howe e , e idences poin o he impo ance o mi ochond ia in i s pa hobiology. Clinical ea u es include mainly mo o -based dys unc ions such as b adykinesia, es ing emo , o cogwheel igidi y [ 6 ]. Those ea u es a e a consequence o he loss o dopamine gic (DA) neu ons in he subs an ia nig a (SN). The associa ion be ween mi ochond ial dys unc ion and he pa hobiology o Pa kinson’s disease was i s desc ibed in 1989. By using pos mo em issue om human pa ien s, a unc ional de iciency was ound on he mi ochond ial Complex I om he espi a o y chain [ 7 , 8 ]. Accumula ing e idence shows he occu ence o mi ochond ia agmen a ion in he con ex o di e en models o he pa hology. Fu he mo e, al e a ion o he exp ession le els o di e en p o eins linked o Pa kinson ´ s disease (e.g., PINK1, Pa kin, o DJ-1) a e known o induce mi ochond ia agmen a ion in DA neu ons [ 9 , 10 ]. Recen ly, i was obse ed ha al e a ions o he mi ochond ial mo phology can be ela ed o hei unc ional s a e and new ools we e consequen ly designed o analyze mi ochond ial shape and p edic mi ochond ial unc ion [11]. In e es ingly, se e al hypo heses o he speci ic loss o he DA neu ons om he SN a e also ela ed o he ulne abili y associa ed wi h he mi ochond ia o hese neu ons [ 12 ]. I has been sugges ed ha DA neu ons om he SN a e mo e suscep ible o oxida i e s ess due o he p oduc ion o eac i e oxygen species (ROS) du ing dopamine deg ada ion, and hese neu ons p esen ewe amoun s o an ioxidan s han o he DA neu ons wi hin he b ain [ 12 ]. They ha e e y long axons in which mi ochond ia a el and also agmen o be able o accommoda e wi hin he synap ic e minals. Besides, i is known ha DA neu ons om he SN p esen lowe mi ochond ia mass in he soma han in he dend i es, indica ing ha al e a ions o ei he agmen a ion o mo emen along he cy oskele on migh ha e a bigge impac on hese neu ons [ 12 ]. Addi ionally, mos o he subs ances ha a e used o model he disease di ec ly a ge he mi ochond ia and induce he speci ic degene a ion o he DA neu ons. In his s udy we made a ho ough li e a u e sea ch o iden i y he mi ochond ial p o eins in ol ed in con olling mi ochond ial mo phology ha a e di e en ially exp essed in Pa kinson’s disease. The al e ed biological pa hways ha migh be a ec ed by changes in he exp ession o hese mi ochond ial-shaping p o eins in Pa kinson’s disease we e iden i ied and analyzed. Conside a ions we e made o be e unde s and he biological mechanisms in ol ed in his debili a ing disease. 2. Me hods Li e a u e Sea ch Fo he compila ion o he mi ochond ial p o eins in ol ed in con olling mi ochond ial mo phology (Table 1), wo independen use s pe o med a sea ch on PubMed, Science Di ec , and Google up o 7 July 2017 using he ollowing keywo ds in sepa a e que ies: “mi ochond ial mo phology”, “mi ochond ial shape”, “mi ochond ial o ganiza ion”, “mi ochond ial usion”, “mi ochond ial ission”, and “mi ochond ial dynamics”. Only Homo sapiens p o eins we e ga he ed. The co esponding gene name and synonyms we e collec ed in Table 1by sea ching a he Uni e sal P o ein Resou ce (UniP o ) da abases [13]. An ioxidan s 2018,7, 1 3 o 45 Table 1. Lis o mi ochond ial-shaping p o eins. Gene Name (wi h Synonyms) P o ein Name Func ion Localiza ion Shaping Func ion Re e ences APOO, FAM121B, MIC23, MIC26, My025, UNQ1866/PRO4302 MICOS Complex subuni MIC26 (Apolipop o ein O) (MICOS Complex subuni MIC23) (P o ein FAM121B) Componen o he MICOS Complex, a la ge p o ein Complex o he inne mi ochond ial memb ane ha plays c ucial oles in he main enance o c is a junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane IMM C is ae shape [14–16] APOOL, CXo 33, FAM121A, MIC27, UNQ8193/PRO23204 MICOS Complex subuni MIC27 (Apolipop o ein O-like) (P o ein FAM121A) Componen o he MICOS Complex, a la ge p o ein Complex o he inne mi ochond ial memb ane ha plays c ucial oles in he main enance o c is a junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane IMM C is ae shape [14,15,17,18] ATP5A1, ATP5B, ATP5C1, ATP5D, ATP5E, ATP5F1, ATP5G1, ATP5G2, ATP5G3, ATP5H, ATP5I, ATP5J, ATP5J2, ATP5L, ATP5O, MT-ATP6, MT-ATP8 ATP syn hase ATP p oduc ion IMM C is ae shape [3,15,19] ATPIF1, ATPI ATPase inhibi o , mi ochond ial (Inhibi o o F(1)F(o)-ATPase) (IF(1)) (IF1) ATP p oduc ion egula ion Ma ix C is ae shape [3,20] BAK1, BAK, BCL2L7, CDN1 Bcl-2 homologous an agonis /kille (Apop osis egula o BAK) P omo es apop osis OMM OMM pe meabiliza ion [3,21] BAX, BCL2L4 Apop osis egula o BAX Accele a es apop osis OMM OMM pe meabiliza ion [3,19,21,22] BCL2 Apop osis egula o Bcl-2 P omo es cell su i al OMM OMM pe meabiliza ion [3,22] BCL2A1, BCL2L5, BFL1, GRS, HBPA1 Bcl-2- ela ed p o ein A1 (A1-A) (Hemopoie ic-speci ic ea ly esponse p o ein) (P o ein BFL-1) P omo es cell su i al OMM No clea unc ion [23,24] BCL2L11, BIM Bcl-2-like p o ein 11 (Bcl2-L-11) (Bcl2-in e ac ing media o o cell dea h) Induces apop osis and anoikis IMM C is ae emodeling [25,26] BID BH3-in e ac ing domain dea h agonis The majo p o eoly ic p oduc p15 BID allows he elease o cy och ome c IMM C is ae emodeling [25,27] BIK, NBK Bcl-2-in e ac ing kille (Apop osis induce NBK) (BIP1) (BP4) P omo es apop osis IMM C is ae emodeling [25,28] CHCHD3, MIC19, MINOS3 MICOS Complex subuni MIC19 (Coiled-coil-helix-coiled-coil-helix domain-con aining p o ein 3) Componen o he MICOS Complex, a la ge p o ein Complex o he inne mi ochond ial memb ane ha plays c ucial oles in he main enance o c is a junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane IMM C is ae shape [14,16,18] An ioxidan s 2018,7, 1 4 o 45 Table 1. Con . Gene Name (wi h Synonyms) P o ein Name Func ion Localiza ion Shaping Func ion Re e ences COA3, CCDC56, MITRAC12, HSPC009 Cy och ome c oxidase assembly ac o 3 homolog, mi ochond ial (Coiled-coil domain-con aining p o ein 56) (Mi ochond ial ansla ion egula ion assembly in e media e o cy och ome c oxidase p o ein o 12 kDa) Co e componen o he MITRAC (mi ochond ial ansla ion egula ion assembly in e media e o cy och ome c oxidase) Complex, which egula es cy och ome c oxidase assembly. IMM Cy och ome c oxidase [29,30] COX4I1, COX4I2, COX5A, COX5B, COX6A1, COX6A2, COX6B1, COX6B2, COX6C, COX7A1, COX7A2, COX7B, COX7B2, COX7C, COX8A, COX8C, MT-CO1, MT-CO2, MT-CO3 Mi ochond ial Complex IV: cy och ome c oxidase subuni s ATP p oduc ion IMM C is ae shape [18] CYC1, MT-CYB, UQCR10, UQCR11, UQCRB, UQCRC1, UQCRC2, UQCRFS1, UQCRH, UQCRQ Mi ochond ial Complex III: ubiquinol-cy och ome c educ ase Complex subuni s (UQCR) ATP p oduc ion IMM C is ae shape [18] DNAJC19, TIM14, TIMM14 Mi ochond ial impo inne memb ane anslocase subuni TIM14 (DnaJ homolog sub amily C membe 19) P obable componen o he PAM Complex, a Complex equi ed o he ansloca ion o ansi pep ide-con aining p o eins om he inne memb ane in o he mi ochond ial ma ix in an ATP-dependen manne IMM C is a shape [15,31,32] DNM1L, DLP1, DRP1 Dynamin-1-like p o ein (EC 3.6.5.5) (Dnm1p/Vps1p-like p o ein) (DVLP) (Dynamin amily membe p oline- ich ca boxyl- e minal domain less) (Dymple) (Dynamin-like p o ein) (Dynamin-like p o ein 4) (Dynamin-like p o ein IV) (HdynIV) (Dynamin- ela ed p o ein 1) Mi ochond ial and pe oxisome di ision OMM and cy osol Fission [3,18,22] DNM2, DYN2 Dynamin-2 (EC 3.6.5.5) Mic o ubule-associa ed o ce-p oducing p o ein in ol ed in p oducing mic o ubule bundles and able o bind and hyd olyze GTP Cy osol Fission [4,33] FIS1, TTC11, CGI-135 Mi ochond ial ission 1 p o ein (FIS1 homolog) (hFis1) (Te a icopep ide epea p o ein 11) (TPR epea p o ein 11) Mi ochond ial agmen a ion OMM Fission [3,19,22] FUNDC1 FUN14 domain-con aining p o ein 1FUN14 domain-con aining p o ein 1 Mi ophagy OMM Fission [29,34–36] GDAP1 Ganglioside-induced di e en ia ion-associa ed p o ein 1 Mi ochond ial ission OMM Fission [1,19,22] h zo1 Mi ochond ial ansmemb ane GTPase Fzo-1 FUNDC1 media es highly selec i e mi ochond ial clea ance unde hypoxic condi ions wi hou impac ing gene al au ophagy OMM Fusion [19] An ioxidan s 2018,7, 1 5 o 45 Table 1. Con . Gene Name (wi h Synonyms) P o ein Name Func ion Localiza ion Shaping Func ion Re e ences IMMT, HMP, MIC60, MINOS2, PIG4, PIG52 MICOS Complex subuni MIC60(Cell p oli e a ion-inducing gene 4/52 p o ein) (Inne mi ochond ial memb ane p o ein) (Mi o ilin) (p87/89) Componen o he MICOS Complex, a la ge p o ein Complex o he inne mi ochond ial memb ane ha plays c ucial oles in he main enance o c is a junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane IMM C is ae shape [15,16,18,19,37] INF2, C14o 151, C14o 173 In e ed o min-2 (HBEBP2-binding p o ein C) Se e s ac in ilamen s and accele a es hei polyme iza ion and depolyme iza ion Cy osol Mi ochond ial cons ic ion [29,38] LETM1 Mi ochond ial p o on/calcium exchange p o ein (Leucine zippe -EF-hand-con aining ansmemb ane p o ein 1) Mi ochond ial p o on/calcium an ipo e ha media es p o on-dependen calcium e lux om mi ochond ia IMM Fission [1,22,39] MARCH5, RNF153 E3 ubiqui in-p o ein ligase MARCH5 (EC 2.3.2.27) (Memb ane-associa ed RING inge p o ein 5) (Memb ane-associa ed RING-CH p o ein V) (MARCH-V) (Mi ochond ial ubiqui in ligase) (MITOL) (RING inge p o ein 153) (RING- ype E3 ubiqui in ans e ase MARCH5) Memb ane-bound E3 ligase o mi ochond ial mo phology con ol OMM Fission [1,19] MAVS, IPS1, KIAA1271, VISA Mi ochond ial an i i al-signaling p o ein (MAVS) (CARD adap e inducing in e e on be a) (Ca di ) (In e e on be a p omo e s imula o p o ein 1) (IPS-1) (Pu a i e NF-kappa-B-ac i a ing p o ein 031N) (Vi us-induced-signaling adap e ) (VISA) Requi ed o inna e immune esponse agains i uses OMM Fusion [22,40] MCL1, BCL2L3 Induced myeloid leukemia cell di e en ia ion p o ein Mcl-1 (Bcl-2-like p o ein 3) (Bcl2-L-3) (Bcl-2- ela ed p o ein EAT/mcl1) (mcl1/EAT) Regula ion o apop osis IMM and OMM C is ae shape (IMM iso o m) [18,29,41,42] MFF, C2o 33, AD030, AD033, GL004 Mi ochond ial Fission Fac o Mi ochond ial and pe oxisome di ision OMM Fission [3,19] MFN1 Mi o usin-1 (EC 3.6.5.-) (Fzo homolog) (T ansmemb ane GTPase MFN1) Mi ochond ial usion OMM Fusion [18,22,43] MFN2, CPRP1, KIAA0214 Mi o usin-2 (EC 3.6.5.-) (T ansmemb ane GTPase MFN2) Regula es mi ochond ial clus e ing and usion OMM Fusion [18,22,43] MIC13, C19o 70, QIL1 MICOS Complex subuni MIC13 (P o ein P117) Componen o he MICOS Complex, a la ge p o ein Complex o he inne mi ochond ial memb ane ha plays c ucial oles in he main enance o c is a junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane IMM C is ae shape [15,18] MIEF1, MID51, SMCR7L Mid51/Mie , mi ochond ial dynamics p o eins o 51 Componen o he MICOS Complex, a la ge p o ein Complex o he inne mi ochond ial memb ane ha plays c ucial oles in he main enance o c is a junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane OMM Fission [3,19] An ioxidan s 2018,7, 1 6 o 45 Table 1. Con . Gene Name (wi h Synonyms) P o ein Name Func ion Localiza ion Shaping Func ion Re e ences MIEF2, MID49, SMCR7 Mi ochond ial dynamics p o ein MID49 (Mi ochond ial dynamics p o ein o 49 kDa) (Mi ochond ial elonga ion ac o 2) (Smi h-Magenis synd ome ch omosomal egion candida e gene 7 p o ein) Componen o he MICOS Complex, a la ge p o ein Complex o he inne mi ochond ial memb ane ha plays c ucial oles in he main enance o c is a junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane OMM Fission [3,19] MIGA1, FAM73A Mi ogua din 1 (P o ein FAM73A) Regula o o mi ochond ial usion OMM Fusion [4,44] MIGA2, C9o 54, FAM73B, PSEC0112 Mi ogua din 2 (P o ein FAM73B) Regula o o mi ochond ial usion OMM Fusion [4,44] MINOS1, C1o 151, MIC10 MICOS Complex subuni MIC10 (Inne mi ochond ial memb ane o ganizing sys em p o ein 1) Main enance o c is ae junc ions, inne memb ane a chi ec u e, and o ma ion o con ac si es o he ou e memb ane IMM C is ae shape [15,18] MTFP1, MTP18, HSPC242, My022 Mi ochond ial ission p ocess p o ein 1(Mi ochond ial 18 kDa p o ein) (MTP18) In ol ed in he mi ochond ial di ision p obably by egula ing memb ane ission IMM Fission [1,22,45] MUL1, C1o 166, GIDE, MAPL, MULAN, RNF218 Mi ochond ial ubiqui in ligase ac i a o o NFKB 1 (EC 2.3.2.27) (E3 SUMO-p o ein ligase MUL1) (E3 ubiqui in-p o ein ligase MUL1) (G ow h inhibi ion and dea h E3 ligase) (Mi ochond ial-ancho ed p o ein ligase) (MAPL) (Pu a i e NF-kappa-B-ac i a ing p o ein 266) (RING inge p o ein 218) (RING- ype E3 ubiqui in ans e ase NFKB 1) Ubiqui in ligase ac i i y OMM Fusion [19,29] NFE2L2, NRF2 Nuclea ac o e y h oid 2- ela ed ac o 2 (NF-E2- ela ed ac o 2) (NFE2- ela ed ac o 2) (HEBP1) (Nuclea ac o , e y h oid de i ed 2, like 2) T ansc ip ion ac i a o ha binds o an ioxidan esponse (ARE) elemen s in he p omo e egions o a ge genes Cy osol Fusion [29,46,47] NRF1 Nuclea espi a o y ac o 1 (NRF-1) (Alpha palind omic-binding p o ein) (Alpha-pal) T ansc ip ion ac o implica ed in he con ol o nuclea genes equi ed o espi a ion, heme biosyn hesis, and mi ochond ial DNA ansc ip ion and eplica ion Cy osol Fission [29,46,48,49] OMA1, MPRP1 Me alloendopep idase OMA1, mi ochond ial (EC 3.4.24.-) (Me allop o ease- ela ed p o ein 1) (MPRP-1) (O e lapping wi h he m-AAA p o ease 1 homolog) Me allop o ease ha is pa o he quali y con ol sys em in he inne memb ane o mi ochond ia IMM Fusion [1,19] OPA1, KIAA0567 Dynamin-like 120 kDa p o ein, mi ochond ial (EC 3.6.5.5) (Op ic a ophy p o ein 1) (Clea ed in o: Dynamin-like 120 kDa p o ein, o m S1) Opa1 media es dynamics changes in c is ae mo phology ha co ela e wi h he me abolic s a e o he o ganelle IMM C is ae shape, usion [1,3,15,18,22,50] PARL, PSARL, PRO2207 P esenilins-associa ed homboid-like p o ein, mi ochond ial (EC 3.4.21.105) (Mi ochond ial in amemb ane clea ing p o ease PARL) (Clea ed in o: P-be a (Pbe a)) Requi ed o he con ol o apop osis IMM Mi ochond ial mo phology [1,51] An ioxidan s 2018,7, 1 7 o 45 Table 1. Con . Gene Name (wi h Synonyms) P o ein Name Func ion Localiza ion Shaping Func ion Re e ences PGAM5 Se ine/ h eonine-p o ein phospha ase PGAM5, mi ochond ial (EC 3.1.3.16) (Bcl-XL-binding p o ein 68) (Phosphoglyce a e mu ase amily membe 5) Displays phospha ase ac i i y o se ine/ h eonine esidues, as well as dephospho yla es and ac i a es MAP3K5 kinase OMM Fission [1,29,52] PHB P ohibi in P ohibi in inhibi s DNA syn hesis; i has a ole in egula ing p oli e a ion IMM C is ae shape [1,15,18,31,53] PHB2, BAP, REA P ohibi in-2 (B-cell ecep o -associa ed p o ein BAP37) (D-p ohibi in) (Rep esso o es ogen ecep o ac i i y) Ac s as a media o o ansc ip ional ep ession by nuclea ho mone ecep o s ia he ec ui men o his one deace ylases (by simila i y); unc ions as an es ogen ecep o (ER)-selec i e co egula o ha po en ia es he inhibi o y ac i i ies o an ies ogens and ep esses he ac i i y o es ogens IMM C is ae shape [1,15,18] PINK1 Se ine/ h eonine-p o ein kinase PINK1, mi ochond ial (EC 2.7.11.1) (BRPK) (PTEN-induced pu a i e kinase p o ein 1) P o ec s agains mi ochond ial dys unc ion du ing cellula s ess by phospho yla ing mi ochond ial p o eins OMM Fission [1,54] PLD6 Mi ochond ial ca diolipin hyd olase (EC 3.1.-.-) (Choline phospha ase 6) (Mi ochond ial phospholipase) (Mi oPLD) (Phospha idylcholine-hyd olyzing phospholipase D6) (Phospholipase D6) (PLD 6) (P o ein zucchini homolog) P oposed o ac as a ca diolipin hyd olase o gene a e phospha idic acid a he mi ochond ial su ace OMM Fusion [4,19,22,45] PPARGC1A, LEM6, PGC1, PGC1A, PPARGC1 Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-alpha (PGC-1-alpha) (PPAR-gamma coac i a o 1-alpha) (PPARGC-1-alpha) (Ligand e ec modula o 6) T ansc ip ional coac i a o o s e oid ecep o s and nuclea ecep o s Cy oplasm and nucleus Fusion [29,49,55] PPARGC1B, PERC, PGC1, PGC1B, PPARGC1 Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-be a (PGC-1-be a) (PPAR-gamma coac i a o 1-be a) (PPARGC-1-be a) (PGC-1- ela ed es ogen ecep o alpha coac i a o ) Plays he ole o s imula o o ansc ip ion ac o s and nuclea ecep o s ac i i ies Nucleus Fusion [29,55,56] PRELID1, PRELI, CGI-106, SBBI12 PRELI domain-con aining p o ein 1, mi ochond ial (25 kDa p o ein o ele an e olu iona y and lymphoid in e es ) (Px19-like p o ein) In ol ed in he modula ion o he mi ochond ial apop o ic pa hway by ensu ing he accumula ion o ca diolipin (CL) in mi ochond ial memb anes In e memb ane space Fission [57,58] PRKN, PARK2 E3 ubiqui in-p o ein ligase pa kin (Pa kin) (EC 2.3.2.-) (Pa kin RBR E3 ubiqui in-p o ein ligase) (Pa kinson ju enile disease p o ein 2) (Pa kinson disease p o ein 2) Func ions wi hin a mul ip o ein E3 ubiqui in ligase Complex, ca alyzing he co alen a achmen o ubiqui in moie ies on o subs a e p o eins Cy osol and mi ochond ia Fission [1,54,59,60] ROMO1, C20o 52 Reac i e oxygen species modula o 1(ROS modula o 1) (Epididymis issue p o ein Li 175) (Gly ichin) (Mi ochond ial a ge ing GxxxG mo i p o ein) (MTGM) (P o ein MGR2 homolog) Induces he p oduc ion o eac i e oxygen species (ROS), which a e necessa y o cell p oli e a ion IMM Fusion [29,61] An ioxidan s 2018,7, 1 8 o 45 Table 1. Con . Gene Name (wi h Synonyms) P o ein Name Func ion Localiza ion Shaping Func ion Re e ences SAMM50, SAM50, CGI-51, TRG3 So ing and assembly machine y componen 50 homolog (T ans o ma ion- ela ed gen 3 p o ein) (TRG-3) Plays a c ucial ole in he main enance o he s uc u e o mi ochond ial c is ae and he p ope assembly o he mi ochond ial espi a o y chain Complexes OMM C is ae shape [18] SH3GLB1, KIAA0491, CGI-61 Endophilin-B1 (Bax-in e ac ing ac o 1) (Bi -1) (SH3 domain-con aining GRB2-like p o ein B1) Ou e mi ochond ial dynamics OMM OMM pe meabili y [1,22,62] SH3GLB2, KIAA1848, PP578 Endophilin-B2 (SH3 domain-con aining GRB2-like p o ein B2) Mi ophagy Cy osol Fission [63] SLC25A10, DIC Mi ochond ial dica boxyla e ca ie (Solu e ca ie amily 25 membe 10) In ol ed in he ansloca ion o malona e, mala e, and succina e in exchange o phospha e, sul a e, sul i e, o hiosul a e ac oss he inne mi ochond ial memb ane IMM C is ae shape [18,50] SLC25A11, SLC20A4 Mi ochond ial 2-oxoglu a a e/mala e ca ie p o ein (OGCP) (Solu e ca ie amily 25 membe 11) Ca alyzes he anspo o 2-oxoglu a a e ac oss he inne mi ochond ial memb ane in an elec oneu al exchange o mala e o o he dica boxylic acids, and plays an impo an ole in se e al me abolic p ocesses, including he mala e-aspa a e shu le, he oxoglu a a e/isoci a e shu le, in gluconeogenesis om lac a e, and in ni ogen me abolism IMM C is ae shape [18,50] SLC25A12, ARALAR1 Calcium-binding mi ochond ial ca ie p o ein A ala 1 (Mi ochond ial aspa a e glu ama e ca ie 1) (Solu e ca ie amily 25 membe 12) Ca alyzes he calcium-dependen exchange o cy oplasmic glu ama e wi h mi ochond ial aspa a e ac oss he inne mi ochond ial memb ane; may ha e a unc ion in he u ea cycle IMM C is ae shape [18,50] SLC25A13, ARALAR2 Calcium-binding mi ochond ial ca ie p o ein A ala 2 (Ci in) (Mi ochond ial aspa a e glu ama e ca ie 2) (Solu e ca ie amily 25 membe 13) Ca alyzes he calcium-dependen exchange o cy oplasmic glu ama e wi h mi ochond ial aspa a e ac oss he inne mi ochond ial memb ane; may ha e a unc ion in he u ea cycle IMM C is ae shape [18,50] SLC25A38 Solu e ca ie amily 25 membe 38, Appop osin Mi ochond ial impo machine y IMM Fusion [29,64] SMAD2, MADH2, MADR2 Mo he s agains decapen aplegic homolog 2 (MAD homolog 2) (Mo he s agains DPP homolog 2) (JV18-1) (Mad- ela ed p o ein 2) (hMAD-2) (SMAD amily membe 2) (SMAD 2) (Smad2) (hSMAD2) Recep o - egula ed SMAD (R-SMAD) ha is an in acellula signal ansduce and ansc ip ional modula o ac i a ed by TGF-be a ( ans o ming g ow h ac o ) and ac i in ype 1 ecep o kinases Cy osol Fusion [29,65] SPG7, CAR, CMAR, PGN Pa aplegin (EC 3.4.24.-) (Cell ma ix adhesion egula o ) (Spas ic pa aplegia 7 p o ein) ATP-dependen zinc me allop o ease IMM C is ae shape [18] SPG7, CAR, CMAR, PGN Pa aplegin (EC 3.4.24.-) (Cell ma ix adhesion egula o ) (Spas ic pa aplegia 7 p o ein) ATP-dependen zinc me allop o ease IMM Fusion [1,22,51] An ioxidan s 2018,7, 1 9 o 45 Table 1. Con . Gene Name (wi h Synonyms) P o ein Name Func ion Localiza ion Shaping Func ion Re e ences STOML2, SLP2, HSPC108 S oma in-like p o ein 2, mi ochond ial(SLP-2) (EPB72-like p o ein 2) (Pa ap o ein a ge 7) (Pa a a g-7) Mi ochond ial p o ein ha p obably egula es he biogenesis and he ac i i y o mi ochond ia; s imula es ca diolipin biosyn hesis, binds ca diolipin-en iched memb anes whe e i ec ui s and s abilizes some p o eins including p ohibi in, and may he e o e ac in he o ganiza ion o unc ional mic odomains in mi ochond ial memb anes IMM C is ae shape/S abilize IM s uc u e [15,18] SYNJ2, KIAA0348 Synap ojanin-2(EC 3.1.3.36) (Synap ic inosi ol 1,4,5- isphospha e 5-phospha ase 2) Memb ane a icking and signaling ansduc ion Cy osol Mi ochond ial agg ega ion [66] TAZ, EFE2, G4.5 Ta azzin (P o ein G4.5) Some iso o ms may be in ol ed in ca diolipin (CL) me abolism OMM C is ae shape [15,16,67,68] TFAM, TCF6, TCF6L2 T ansc ip ion ac o A, mi ochond ial (m TFA) (Mi ochond ial ansc ip ion ac o 1) (M TF1) (T ansc ip ion ac o 6) (TCF-6) (T ansc ip ion ac o 6-like 2) Binds o he mi ochond ial ligh s and p omo e and unc ions in mi ochond ial ansc ip ion egula ion Ma ix Mi ochond ial biogenesis [29,46] TRAK1, KIAA1042, OIP106 T a icking kinesin-binding p o ein 1 (106 kDa O-GlcNAc ans e ase-in e ac ing p o ein) O ganelle a icking OMM and cy osol Fusion [1,4,19] TRAK2, ALS2CR3, KIAA0549 T a icking kinesin-binding p o ein 2 (Amyo ophic la e al scle osis 2 ch omosomal egion candida e gene 3 p o ein) O ganelle a icking OMM and cy osol Fusion [1,4,19] UQCC3, C11o 83, UNQ655/PRO1286 Ubiquinol-cy och ome-c educ ase Complex assembly ac o 3 Requi ed o he assembly o he ubiquinol-cy och ome c educ ase Complex (mi ochond ial espi a o y chain Complex III o cy och ome b-c1 Complex), media ing cy och ome b ec ui men and p obably s abiliza ion wi hin he Complex IMM C is ae shape [18,69] VAT1 Synap ic esicle memb ane p o ein VAT-1 homolog (EC 1.-.-.-) (Mi o usin-binding p o ein) (P o ein MIB) Nega i ely egula es mi ochond ial usion OMM Fusion [1,19,22,70] YME1L1, FTSH1, YME1L, UNQ1868/PRO4304 ATP-dependen zinc me allop o ease YME1L1 (EC 3.4.24.-) (ATP-dependen me allop o ease F sH1) (Meg-4) (P esenilin-associa ed me allop o ease) (PAMP) (YME1-like p o ein 1) Pu a i e ATP-dependen p o ease; plays a ole in mi ochond ial o ganiza ion and mi ochond ial p o ein me abolism, including he deg ada ion o PRELID1 and OPA1 IMM C is ae shape [19,58] An ioxidan s 2018,7, 1 16 o 45 Table 3. Con . Gene Names P o ein Names NDUFS1 NADH-ubiquinone oxido educ ase 75 kDa subuni , mi ochond ial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-75kD) (CI-75kD) NDUFS3 NADH dehyd ogenase (ubiquinone) i on-sul u p o ein 3, mi ochond ial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxido educ ase 30 kDa subuni ) NEDD8 NEDD8 (Neddylin) (Neu al p ecu so cell exp essed de elopmen ally down egula ed p o ein 8) (NEDD-8) (Ubiqui in-like p o ein Nedd8) NPM1, NPM Nucleophosmin (NPM) (Nucleola phosphop o ein B23) (Nucleola p o ein NO38) (Numa in) OAT O ni hine amino ans e ase, mi ochond ial (EC 2.6.1.13) (O ni hine del a-amino ans e ase) (O ni hine—oxo-acid amino ans e ase) (Clea ed in o: O ni hine amino ans e ase, hepa ic o m; O ni hine amino ans e ase, enal o m) OGDH 2-oxoglu a a e dehyd ogenase, mi ochond ial (EC 1.2.4.2) (2-oxoglu a a e dehyd ogenase complex componen E1) (OGDC-E1) (Alpha-ke oglu a a e dehyd ogenase) OTUB1, OTB1, OTU1, HSPC263 Ubiqui in hioes e ase OTUB1 (EC 3.4.19.12) (Deubiqui ina ing enzyme OTUB1) (OTU domain-con aining ubiqui in aldehyde-binding p o ein 1) (O ubain-1) (hOTU1) (Ubiqui in-speci ic-p ocessing p o ease OTUB1) PDIA3, ERP57, ERP60, GRP58 P o ein disul ide-isome ase A3 (EC 5.3.4.1) (58 kDa glucose- egula ed p o ein) (58 kDa mic osomal p o ein) (p58) (Disul ide isome ase ER-60) (Endoplasmic e iculum esiden p o ein 57) (ER p o ein 57) (ERp57) (Endoplasmic e iculum esiden p o ein 60) (ER p o ein 60) (ERp60) PGK1, PGKA, MIG10, OK/SW-cl.110 Phosphoglyce a e kinase 1 (EC 2.7.2.3) (Cell mig a ion-inducing gene 10 p o ein) (P ime ecogni ion p o ein 2) (PRP 2) PHB P ohibi in PHB2, BAP, REA P ohibi in-2 (B-cell ecep o -associa ed p o ein BAP37) (D-p ohibi in) (Rep esso o es ogen ecep o ac i i y) PIN1 Pep idyl-p olyl cis- ans isome ase NIMA-in e ac ing 1 (EC 5.2.1.8) (Pep idyl-p olyl cis- ans isome ase Pin1) (PPIase Pin1) (Ro amase Pin1) PPIA, CYPA Pep idyl-p olyl cis- ans isome ase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclospo in A-binding p o ein) (Ro amase A) (Clea ed in o: Pep idyl-p olyl cis- ans isome ase A, N- e minally p ocessed) PRDX4 Pe oxi edoxin-4 (EC 1.11.1.15) (An ioxidan enzyme AOE372) (AOE37-2) (Pe oxi edoxin IV) (P x-IV) (Thio edoxin pe oxidase AO372) (Thio edoxin-dependen pe oxide educ ase A0372) PSMA3, HC8, PSC8 P o easome subuni alpha ype-3 (EC 3.4.25.1) (Mac opain subuni C8) (Mul i-ca aly ic endopep idase complex subuni C8) (P o easome componen C8) PTPN5 Ty osine-p o ein phospha ase non- ecep o ype 5 (EC 3.1.3.48) (Neu al-speci ic p o ein- y osine phospha ase) (S ia um-en iched p o ein- y osine phospha ase) (STEP) RAB14 Ras- ela ed p o ein Rab-14 RAB2A, RAB2 Ras- ela ed p o ein Rab-2A RAC1, TC25, MIG5 Ras- ela ed C3 bo ulinum oxin subs a e 1 (Cell mig a ion-inducing gene 5 p o ein) (Ras-like p o ein TC25) (p21-Rac1) RAPGEF2, KIAA0313, NRAPGEP, PDZGEF1 Rap guanine nucleo ide exchange ac o 2 (Cyclic nucleo ide as GEF) (CN asGEF) (Neu al RAP guanine nucleo ide exchange p o ein) (nRap GEP) (PDZ domain-con aining guanine nucleo ide exchange ac o 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associa ing GEF-1) RHOA, ARH12, ARHA, RHO12 T ans o ming p o ein RhoA (Rho cDNA clone 12) (h12) RNH1, PRI, RNH Ribonuclease inhibi o (Placen al ibonuclease inhibi o ) (Placen al RNase inhibi o ) (Ribonuclease/angiogenin inhibi o 1) (RAI) RPN1 Dolichyl-diphosphooligosaccha ide—p o ein glycosyl ans e ase subuni 1 (Dolichyl-diphosphooligosaccha ide—p o ein glycosyl ans e ase 67 kDa subuni ) (Ribopho in I) (RPN-I) (Ribopho in-1) RPN2 Dolichyl-diphosphooligosaccha ide—p o ein glycosyl ans e ase subuni 2 (Dolichyl-diphosphooligosaccha ide—p o ein glycosyl ans e ase 63 kDa subuni ) (RIBIIR) (Ribopho in II) (RPN-II) (Ribopho in-2) RPS15A, OK/SW-cl.82 40S ibosomal p o ein S15a (Small ibosomal subuni p o ein uS8) RPS3, OK/SW-cl.26 40S ibosomal p o ein S3 (EC 4.2.99.18) (Small ibosomal subuni p o ein uS3) S100A10, ANX2LG CAL1L CLP11 P o ein S100-A10 (Calpac in I ligh chain) (Calpac in-1 ligh chain) (Cellula ligand o annexin II) (S100 calcium-binding p o ein A10) (p10 p o ein) (p11) An ioxidan s 2018,7, 1 17 o 45 Table 3. Con . Gene Names P o ein Names SAMM50, SAM50 CGI-51 TRG3 So ing and assembly machine y componen 50 homolog (T ans o ma ion- ela ed gene 3 p o ein) (TRG-3) SELENBP1, SBP Selenium-binding p o ein 1 (56 kDa selenium-binding p o ein) (SBP56) (SP56) SFXN1 Side o lexin-1 (T ica boxyla e ca ie p o ein) (TCC) SH3GLB2, KIAA1848, PP578 Endophilin-B2 (SH3 domain-con aining GRB2-like p o ein B2) SIRT2, SIR2L, SIR2L2 NAD-dependen p o ein deace ylase si uin-2 (EC 3.5.1.-) (Regula o y p o ein SIR2 homolog 2) (SIR2-like p o ein 2) SLC25A13, ARALAR2 Calcium-binding mi ochond ial ca ie p o ein A ala 2 (Ci in) (Mi ochond ial aspa a e glu ama e ca ie 2) (Solu e ca ie amily 25 membe 13) SLC25A18, GC2 Mi ochond ial glu ama e ca ie 2 (GC-2) (Glu ama e/H(+) sympo e 2) (Solu e ca ie amily 25 membe 18) SLC25A5, ANT2 ADP/ATP anslocase 2 (ADP, ATP ca ie p o ein 2) (ADP, ATP ca ie p o ein, ib oblas iso o m) (Adenine nucleo ide ansloca o 2) (ANT 2) (Solu e ca ie amily 25 membe 5) (Clea ed in o: ADP/ATP anslocase 2, N- e minally p ocessed) SLC9A3R1, NHERF, NHERF1 Na(+)/H(+) exchange egula o y co ac o NHE-RF1 (NHERF-1) (Ez in- adixin-moesin-binding phosphop o ein 50) (EBP50) (Regula o y co ac o o Na(+)/H(+) exchange ) (Sodium-hyd ogen exchange egula o y ac o 1) (Solu e ca ie amily 9 iso o m A3 egula o y ac o 1) SSBP1, SSBP Single-s anded DNA-binding p o ein, mi ochond ial (M -SSB) (M SSB) (PWP1-in e ac ing p o ein 17) TPD52 Tumo p o ein D52 (P o ein N8) TPM1, C15o 13, TMSA T opomyosin alpha-1 chain (Alpha- opomyosin) (T opomyosin-1) TPM2, TMSB T opomyosin be a chain (Be a- opomyosin) (T opomyosin-2) TPM3 T opomyosin alpha-3 chain (Gamma- opomyosin) (T opomyosin-3) (T opomyosin-5) (hTM5) TPM4 T opomyosin alpha-4 chain (TM30p1) (T opomyosin-4) TUBA1A, TUBA3 Tubulin alpha-1A chain (Alpha- ubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) (Clea ed in o: De y osina ed ubulin alpha-1A chain) TUBB, TUBB5, OK/SW-cl.56 Tubulin be a chain (Tubulin be a-5 chain) TUBB4B, TUBB2C Tubulin be a-4B chain (Tubulin be a-2 chain) (Tubulin be a-2C chain) TUFM Elonga ion ac o Tu, mi ochond ial (EF-Tu) (P43) UQCRB, UQBP Cy och ome b-c1 complex subuni 7 (Complex III subuni 7) (Complex III subuni VII) (QP-C) (Ubiquinol-cy och ome c educ ase complex 14 kDa p o ein) UQCRFS1 Cy och ome b-c1 complex subuni Rieske, mi ochond ial (EC 1.10.2.2) (Complex III subuni 5) (Cy och ome b-c1 complex subuni 5) (Rieske i on-sul u p o ein) (RISP) (Ubiquinol-cy och ome c educ ase i on-sul u subuni ) (Clea ed in o: Cy och ome b-c1 complex subuni 11 (Complex III subuni IX) (Ubiquinol-cy och ome c educ ase 8 kDa p o ein)) UQCRFS1P1, UQCRFSL1 Pu a i e cy och ome b-c1 complex subuni Rieske-like p o ein 1 (Ubiquinol-cy och ome c educ ase Rieske i on-sul u subuni pseudogene 1) UQCRH Cy och ome b-c1 complex subuni 6, mi ochond ial (Complex III subuni 6) (Complex III subuni VIII) (Cy och ome c1 non-heme 11 kDa p o ein) (Mi ochond ial hinge p o ein) (Ubiquinol-cy och ome c educ ase complex 11 kDa p o ein) USMG5, DAPIT, HCVFTP2, PD04912 Up egula ed du ing skele al muscle g ow h p o ein 5 (Diabe es-associa ed p o ein in insulin-sensi i e issues) (HCV F- ansac i a ed p o ein 2) VCP T ansi ional endoplasmic e iculum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subuni ) (Valosin-con aining p o ein) (VCP) VDAC1, VDAC Vol age-dependen anion-selec i e channel p o ein 1 (VDAC-1) (hVDAC1) (Ou e mi ochond ial memb ane p o ein po in 1) (Plasmalemmal po in) (Po in 31HL) (Po in 31HM) VDAC2 Vol age-dependen anion-selec i e channel p o ein 2 (VDAC-2) (hVDAC2) (Ou e mi ochond ial memb ane p o ein po in 2) VDAC3 Vol age-dependen anion-selec i e channel p o ein 3 (VDAC-3) (hVDAC3) (Ou e mi ochond ial memb ane p o ein po in 3) VIM Vimen in YWHAE 14-3-3 p o ein epsilon (14-3-3E) YWHAZ 14-3-3 p o ein ze a/del a (Fac o ac i a ing exoenzyme S) (FAS) (P o ein kinase C inhibi o p o ein 1) (KCIP-1) An ioxidan s 2018,7, 1 18 o 45 An ioxidan s 2018, 7, 1 16 o 48 ubiquinol cy och ome c educ ase i on–sulphu subuni , and he cy och ome b-c1 Complex subuni 6) and Complex IV ( he cy och ome c oxidase subuni 4, he cy och ome c oxidase subuni 5A, he cy och ome c oxidase subuni 6C, he cy och ome c oxidase subuni 7C, and he cy och ome c oxidase polypep ide I). Pi o al o he p ope a chi ec u e o he mi ochond ial c is ae is he p o ein OPA1 [3]. Al e a ions we e ound o occu in he exp ession o he calcium-binding mi ochond ial ca ie p o ein A ala 2 (Slc25A), which ac s in conjunc ion wi h OPA1 o sense modi ica ions o he subs a e le els o ene gy p oduc ion. Following his in e ac ion, he c is ae a e na owed and he dime iza ion o he ATP syn hase is s imula ed [18]. The mi ochond ial c is ae s uc u e is no solely main ained by p o eins, bu also by ca diolipin lipids [18], and se e al ca diolipin binding p o eins ha e been desc ibed o be p esen a he mi ochond ial memb ane, amongs hem he P ohibi in p o ein amily. P ohibi in and P ohibi in-2 appea ed o be al e ed in he con ex o Pa kinson’s disease in ou analysis (Table 2). These p o eins a e known o be o ganized in complexes wi hin he inne mi ochond ial memb ane and a e impo an o he p ope o ganiza ion o he c is ae mo phology and mi ochond ial espi a ion [53,92]. Mo eo e , hese p o eins a e in ol ed in he u no e o he subuni s o he mi ochond ial espi a o y chain and pa icipa e in he assembly o he Complex IV om he espi a o y chain [93,94]. The e is e idence ha abe an c is ae mo phology a ec s he p ope assembly o he OXPHOS complexes, bu also ha he lack o ATP syn hase subuni s impac s he mo phology o he c is ae [95,96]. The la e has been suppo ed by s udies showing ha ATP syn hase dime iza ion o ces memb ane cu a u e [97]. In e es ingly, mi ochond ial mo phology also elies on he cellula ene ge ic s a e since, by comp omising mi ochond ial memb ane po en ial, mi ochond ial agmen a ion is induced [98]. In addi ion, dime o ma ion o he F1F0-ATP syn hase a ec s mi ochond ial c is ae s uc u e [95]. 3.2. Binding Pa ne s o Mi ochond ial P o eins Di e en ially Exp essed in Pa kinson’s Disease Mi ochond ia a e o ganelles wi h impo an oles in many cellula p ocesses, hence we nex explo ed he binding pa ne s desc ibed o he mi ochond ial p o eins di e en ially exp essed in Pa kinson’s disease (Table 2). Using he HIPPIE ool [72,99–101], we de e mined he comple e lis o binding pa ne s, which is depic ed in Supplemen a y Table S2 (Figu e 1). This so wa e p o ides in o ma ion on human p o ein-p o ein in e ac ions wi h high con idence sco es ha a e due o he amoun o suppo ing da a a ailable as well as de i ed om anno a ed in o ma ion [72,99]. In o al, o he 22 mi ochond ial-shaping p o eins al e ed in Pa kinson’s disease, we ound 1683 hin s o in e ac ing p o eins. Since some o he mi ochond ial-shaping p o eins ha e in e ac ing p o eins in common, hese hin s co espond o 1008 di e en p o eins. When we c oss- e e enced hese binding pa ne s wi h he lis o p o eins ound o be modi ied in he con ex o Pa kinson’s disease (Supplemen a y Table S1), 108 common hin s we e iden i ied (Figu e 3, Table 3, and Supplemen a y Table S3). In Supplemen a y Table S3, he di e en hin s o he p o eins lis ed in Table 3 wi hin he di e en p o eomics-based s udies used in he p esen wo k a e desc ibed. Figu e 3. Venn diag am displaying he compa ison o he numbe o he binding pa ne s o he mi ochond ial-shaping p o eins a ec ed in Pa kinson’s disease (Table 2) and he p o eins ound o be di e en ially exp essed in he con ex o Pa kinson’s disease (Supplemen a y Table S1). The Venn diag am was cons uc ed using he Venny 2.1 so wa e [71]. PD—Pa kinson’s disease. Figu e 3. Venn diag am displaying he compa ison o he numbe o he binding pa ne s o he mi ochond ial-shaping p o eins a ec ed in Pa kinson’s disease (Table 2) and he p o eins ound o be di e en ially exp essed in he con ex o Pa kinson’s disease (Supplemen a y Table S1). The Venn diag am was cons uc ed using he Venny 2.1 so wa e [71]. PD—Pa kinson’s disease. The p o eins used o sea ch o he binding pa ne s we e mi ochond ial p o eins, hus al e a ions in he mi ochond ial cellula componen s we e expec ed. In his ega d, he down egula ion o he inne mi ochond ial memb ane and he mi ochond ial p o on- anspo ing ATP syn hase complex was an icipa ed. Se e al o he p o eins ound o be al e ed in he con ex o Pa kinson’s disease (Table 2) a e p o eins loca ed a he inne mi ochond ial memb ane, and he al e a ion o hese componen s has also p e iously been desc ibed in he pa hology [7]. In e es ingly, i has been shown ha he ubiqui in-p o easome sys em egula es he le el o p o eins a ge ed o he mi ochond ial in e memb ane space, and his p ocess depends on he mi ochond ial in e memb ane space impo machine y [ 102 ]. Addi ionally, i has been shown ha he ubiqui in-p o easome sys em ac s on he egula ion o he mi ochond ial biogenesis [ 103 ]. In his s udy, we ound an up egula ion o he p o easome, which co obo a es he e idence o i s dys unc ion in Pa kinson’s disease [ 103 , 104 ]. ROS le els a e inc eased in Pa kinson’s disease and a e esponsible o he oxida i e modi ica ion o lipids, DNA, and p o eins [ 105 ]. These modi ica ions migh lead o mis olded p o eins and agg ega ion [ 106 ]. Mi ochond ial p o eins migh be dys unc ional due o he ha m ul e ec s o ROS, which no only migh modi y he olded p o eins, bu also a ec he inco po a ion o newly syn he ized mi ochond ial p o eins since hey a e ansla ed in he cy osol and mus be anspo ed un olded in o he mi ochond ia [ 103 ]. In an oxida i e s ess scena io, as in Pa kinson’s disease, he isk o he al e a ion o un olded p o eins and consequen emo al by he p o easome is highe , educing he amoun o mi ochond ial p o eins a ailable. Besides, i is known ha ou e mi ochond ial memb ane p o eins in ol ed in mi ochond ial usion a e egula ed by ubiqui ina ion and ha his p ocess is induced by s ess [19]. Mi ochond ial dynamics no only elies on mi ochond ial usion and ission p o eins, bu also on he con ac si es be ween mi ochond ia and he ER, which a e undamen al o he ini ial ission p ocess [ 107 ]. I has been desc ibed ha he shape- o ming p o eins con ol mi ochond ial mo phology by media ing he a achmen o he mi ochond ia o he cy oskele on and he ER [ 107 , 108 ], and hey can also connec he inne and ou e mi ochond ial memb anes, hence in luencing he impo and assembly o mi ochond ial p o eins [ 109 ]. Rega ding he up egula ion o he melanosome as a cellula componen , al hough i is an o ganelle no p esen in neu onal cells, when we look closely a he p o eins con ibu ing o his node, we ind ha h ee o he p o eins a e hea shock p o eins. These p o eins a e key componen s in ensu ing p ope p o ein unc ion and a e exp essed in esponse o s ess, con olling he subsequen deg ada ion o mis olded p o eins, which is also in line wi h he up egula ion o he p o easome complex and he occu ence o he oxida i e s ess cha ac e is ic o he diso de . The mi ochond ial cy och ome bc1 complex om he espi a o y chain (Complex III) is one o he main p oduce s o ROS, oge he wi h he Complex I [ 110 ]. Al hough Complex I elease supe oxide in o he mi ochond ial ma ix, Complex III does i in o he in e memb ane space and he cy osol [ 111 ]. In he pa hobiology o Pa kinson’s disease, i is well accep ed ha he e is an inc ease in ROS leading An ioxidan s 2018,7, 1 19 o 45 o oxida i e s ess [ 105 ], which is in ag eemen wi h he up egula ion o he cellula mi ochond ia componen o he espi a o y chain Complex III ound in ou analysis. This complex is localized in he inne mi ochond ial memb ane, a he c is ae, and has h ee ansmemb ane subuni s in which he p os he ic g oups in ol ed in he edox eac ions a e loca ed. They mus be dime ized o p ope unc ioning, which is also dependen on he mi ochond ial memb ane po en ial [ 110 ], sugges ing ha al e a ions in he o ganiza ion o he inne mi ochond ial memb ane migh a ec hei unc ion. An ioxidan s 2018, 7, 1 22 o 48 bu also a ec he inco po a ion o newly syn he ized mi ochond ial p o eins since hey a e ansla ed in he cy osol and mus be anspo ed un olded in o he mi ochond ia [103]. In an oxida i e s ess scena io, as in Pa kinson’s disease, he isk o he al e a ion o un olded p o eins and consequen emo al by he p o easome is highe , educing he amoun o mi ochond ial p o eins a ailable. Besides, i is known ha ou e mi ochond ial memb ane p o eins in ol ed in mi ochond ial usion a e egula ed by ubiqui ina ion and ha his p ocess is induced by s ess [19]. Figu e 4. Cy oscape ne wo k o he main cellula componen s associa ed wi h mi ochond ial-shaping p o eins in he con ex o Pa kinson’s disease. The binding pa ne s o he mi ochond ial-shaping p o eins ound o be modi ied in di e en p o eomics-based app oaches in he con ex o Pa kinson’s disease acco ding o he Human In eg a ed P o ein-P o ein In e ac ion E e ence (HIPPIE) and appea ing as modi ied in p o eomics-based s udies on Pa kinson’s disease we e subjec ed o ne wo k analysis using he plugin ClueGo om he so wa e Cy oscape o analyze he cellula componen s ep esen ed by he p o eins om he lis . G ay scale nodes co espond o cellula componen s ha we e ound o be equally up- and down egula ed in di e en s udies, while g een and ed nodes a e ep esen a i e o up egula ed and down egula ed cellula componen s espec i ely, in he con ex o Pa kinson’s disease. The inc ease in g een and ed colo g adien ep esen s highe amoun s o he con ibu ion o up- and down egula ed p o eins, espec i ely. The size o he nodes is indica i e o hei s a is ical signi icance. Figu e 4. Cy oscape ne wo k o he main cellula componen s associa ed wi h mi ochond ial-shaping p o eins in he con ex o Pa kinson’s disease. The binding pa ne s o he mi ochond ial-shaping p o eins ound o be modi ied in di e en p o eomics-based app oaches in he con ex o Pa kinson’s disease acco ding o he Human In eg a ed P o ein-P o ein In e ac ion E e ence (HIPPIE) and appea ing as modi ied in p o eomics-based s udies on Pa kinson’s disease we e subjec ed o ne wo k analysis using he plugin ClueGo om he so wa e Cy oscape o analyze he cellula componen s ep esen ed by he p o eins om he lis . G ay scale nodes co espond o cellula componen s ha we e ound o be equally up- and down egula ed in di e en s udies, while g een and ed nodes a e ep esen a i e o up egula ed and down egula ed cellula componen s espec i ely, in he con ex o Pa kinson’s disease. The inc ease in g een and ed colo g adien ep esen s highe amoun s o he con ibu ion o up- and down egula ed p o eins, espec i ely. The size o he nodes is indica i e o hei s a is ical signi icance. An ioxidan s 2018,7, 1 20 o 45 A close look a he ne wo k shows ha “muscle hin ilamen opomyosin” is connec ed o cellula componen s ela ed o he ac in cy oskele on (“ac in ilamen ”, “s ess ibe ”, and “ ilamen ous ac in”). As desc ibed abo e, he cy oskele on also plays a ole in he dynamics and mo emen o he mi ochond ia [ 108 ]. In e es ingly, in he con ex o Pa kinson’s disease some models (bo h gene ic and d ug-based) showed a nega i e impac on he dynamics o he ac in cy oskele on and he o ma ion o s ess ibe s [108,112,113]. 3.3. Biological P ocesses Associa ed wi h Mi ochond ial-Shaping P o eins A ec ed in Pa kinson’s Disease To ob ain in o ma ion on he biological p ocesses ela ed o he mi ochond ial-shaping p o eins a ec ed in Pa kinson’s disease, we unde ook a bioin o ma ic app oach using he plugin ClueGo om he Cys oscope so wa e (Figu e 5and Table 4). This plugin allows he ex ac ion o he biological meaning o la ge lis s o p o eins [ 114 ]. O e all, a ound 44% al e ed p ocesses a e ela ed o ene gy p oduc ion by he mi ochond ia. This con ibu ion was expec ed since he dys unc ion o his o ganelle is a hallma k o he disease. An ioxidan s 2018, 7, 1 24 o 48 Figu e 5. Cy oscape ne wo k o he main biological p ocesses associa ed wi h mi ochond ial-shaping p o eins in he con ex o Pa kinson’s disease. The binding pa ne s o he mi ochond ial-shaping p o eins ound modi ied in di e en p o eomics-based app oaches in he con ex o Pa kinson’s disease we e subjec ed o ne wo k analysis using he plugin ClueGo om he so wa e Cy oscape o analyze he biological p ocesses a ec ed in he disease. G ay scale nodes co espond o biological pa hways ha we e ound o be equally up- and down egula ed in di e en s udies, while g een and ed nodes a e ep esen a i e o up egula ed and down egula ed biological pa hways, espec i ely, in he con ex o Pa kinson’s disease. The inc ease in g een and ed colo g adien ep esen s highe amoun s o he con ibu ion o up- and down egula ed p o eins, espec i ely. The size o he nodes is indica i e o hei s a is ical signi icance. Table 4. Lis o biological p ocesses ela ed o he mi ochond ial-shaping p o eins a ec ed in Pa kinson’s disease. Up egula ed Down egula ed ATP biosyn he ic p ocess ATP me abolic p ocess Posi i e egula ion o ni ic oxide biosyn he ic p ocess Memb ane a assembly Response o un olded p o ein Posi i e egula ion o s ess ibe assembly Audi o y ecep o cell mo phogenesis Glu ha ione de i a i e biosyn he ic p ocess Binding o spe m o zona pellucida P o ein N-linked glycosyla ion ia aspa agine Regula ion o p o ein dephospho yla ion Glucoco icoid ecep o signaling pa hway Mi ochond ial elec on anspo ubiquinol o cy och ome c ER-nucleus signaling pa hway Regula ion o exi om mi osis Subs an ia nig a de elopmen NAD me abolic p ocess Posi i e egula ion o NFkB signaling Muscle ilamen sliding Mi ochond ial ansmemb ane anspo Regula ion o complemen ac i a ion Mi ochond ial elec on anspo cy och ome c o oxygen Midb ain de elopmen and posi i e egula ion o Respi a o y elec on anspo chain Figu e 5. Cy oscape ne wo k o he main biological p ocesses associa ed wi h mi ochond ial-shaping p o eins in he con ex o Pa kinson’s disease. The binding pa ne s o he mi ochond ial-shaping p o eins ound modi ied in di e en p o eomics-based app oaches in he con ex o Pa kinson’s disease we e subjec ed o ne wo k analysis using he plugin ClueGo om he so wa e Cy oscape o analyze he biological p ocesses a ec ed in he disease. G ay scale nodes co espond o biological pa hways ha we e ound o be equally up- and down egula ed in di e en s udies, while g een and ed nodes a e ep esen a i e o up egula ed and down egula ed biological pa hways, espec i ely, in he con ex o Pa kinson’s disease. The inc ease in g een and ed colo g adien ep esen s highe amoun s o he con ibu ion o up- and down egula ed p o eins, espec i ely. The size o he nodes is indica i e o hei s a is ical signi icance. An ioxidan s 2018,7, 1 21 o 45 Table 4. Lis o biological p ocesses ela ed o he mi ochond ial-shaping p o eins a ec ed in Pa kinson’s disease. Up egula ed Down egula ed ATP biosyn he ic p ocess ATP me abolic p ocess Posi i e egula ion o ni ic oxide biosyn he ic p ocess Memb ane a assembly Response o un olded p o ein Posi i e egula ion o s ess ibe assembly Audi o y ecep o cell mo phogenesis Glu ha ione de i a i e biosyn he ic p ocess Binding o spe m o zona pellucida P o ein N-linked glycosyla ion ia aspa agine Regula ion o p o ein dephospho yla ion Glucoco icoid ecep o signaling pa hway Mi ochond ial elec on anspo ubiquinol o cy och ome c ER-nucleus signaling pa hway Regula ion o exi om mi osis Subs an ia nig a de elopmen NAD me abolic p ocess Posi i e egula ion o NFkB signaling Muscle ilamen sliding Mi ochond ial ansmemb ane anspo Regula ion o complemen ac i a ion Mi ochond ial elec on anspo cy och ome c o oxygen Midb ain de elopmen and posi i e egula ion o neu ophil chemo axis Respi a o y elec on anspo chain Oxida i e phospho yla ion Mi ochond ial espi a o y chain Complex I assembly Mi ochond ial elec on anspo NADH o ubiquinone Mi ochond ia espi a o y chain complex assembly Mi ochond ial ATP syn hesis coupled o elec on anspo Cellula espi a ion and p o on anspo In e es ingly, o he biological p ocesses a e ela ed o he occu ence o oxida i e s ess and he espec i e al e a ions in p o eins, which is also a known cha ac e is ic o Pa kinson’s disease [ 105 ]. In his ega d, he posi i e egula ion o he ni ic oxide (NO) biosyn he ic p ocess ha e been shown o occu in his diso de , which is ele an o neu onal dea h. When NO syn hases a e abla ed, animals a e p o ec ed agains he e ec o he MPTP oxin [ 115 ]. I is also known ha NO no only induces oxida i e s ess bu also neu onal dea h [ 116 , 117 ]. The down egula ion o he glu a hione de i a i e biosyn he ic p ocess is also a cha ac e is ic o an oxida i e s ess scena io, which has also been desc ibed in Pa kinson’s disease [ 118 ]. This pep ide ac s as a cellula an ioxidan , which is p oduced by neu ons and glial cells, and i has been p oposed as an impo an molecule o he apeu ic pu poses in he con ex o Pa kinson’s disease [ 118 , 119 ]. Mo eo e , he up egula ion o he esponse o un olded p o eins is impo an in an oxida i e s ess scena io whe e p o eins and pep ides can be oxida i ely modi ied wi h a ha m ul e ec on hei h ee-dimensional (3D) s uc u e, wi h agg ega ion ha ing a nega i e impac on hei unc ion [ 106 ]. Besides, p o ein oxida i e modi ica ions and agg ega ion ha e been also ela ed o he dec eased in glu a hione le els [120]. As s a ed along his wo k, he cellula cy oskele on is one o he mechanisms con ibu ing o he de ini ion o mi ochond ial mo phology [ 108 ]. In ac , modi ica ion o he ac in cy oskele on has been p obed in Pa kinson’s disease [ 108 , 112 , 113 ]. Mi ochond ial usion and ission p ocesses a e a ec ed by he in e ac ion o he mi ochond ia wi h he cy oskele on. I has been desc ibed ha he usion p ocess can be delayed when ac in ilamen s a e depolyme ized [ 121 ]. The ac in cy oskele on is also in ol ed in he ission p ocess [ 38 ]. In ou ne wo k, se e al p ocesses a e ela ed o he ac in cy oskele on, such as he up egula ion o he p ocess o “muscle ilamen sliding” and he down egula ion o he “posi i e egula ion o s ess ibe assembly”. In e es ingly, a e a close look a he modi ied biological p ocess o “binding o spe m o zona pellucida”, we obse ed ha he p o eins connec ed o his p ocess a e molecula chape ones and, ema kably, TCP-1-epsilon is known o play a ole in he olding o ac in and ubulin [122]. Rega ding he “audi o y ecep o cell mo phogenesis” biological p ocesses, i is impo an o no e ha he p o ein Rac1 con ibu es o his pa hway and is in ol ed in he egula ion o sec e o y p ocesses, he phagocy osis o dea h cells, cell pola iza ion, and he o ma ion o memb ane u les. In he con ex o Pa kinson’s disease, i has been shown o con ibu e o a ROS gene a ing pa hway An ioxidan s 2018,7, 1 22 o 45 ac ing wi h Nox1, causing neu onal dea h [ 123 ]. In e es ingly, he o he componen o his node is he NHERF-1 p o ein, which has been shown o ac as a sca old o connec ing plasma memb ane p o eins wi h membe s o he ERM (ez in/moesin/ adixin) amily, aiding in hei link o he ac in cy oskele on o he egula ion o hei su ace exp ession [124]. Wi hin he highligh ed p ocess o “ egula ion o p o ein dephospho yla ion” in ol ed in he egula ion o p o ein unc ion, we ound an in e es ing p o ein con ibu ion o his pa hway: he Pep idyl-p olyl cis- ans isome ase (Pin1). This p o ein has been shown o be in ol ed in he disease, being up egula ed in cellula and animal models as well as in SN in pa ien s [ 125 ]. The al e a ion o his biological p ocess migh ha e an impac on s ess esponses, immune unc ion, and neu onal su i al [ 126 ]. Also, his pa hway is undamen al o p ope mi ochond ial unc ioning and signaling since, in esponse o he me abolic s a e o he cell, mi ochond ial p o eins om he impo machine y migh be egula ed by phospho yla ion [127]. In he “ egula ion o exi om mi osis” p ocess, wo in e es ing p o eins eme ge: P ohibi in-2 and he NAD-dependen p o ein deace ylase si uin-2. The la e deace yla es lysines on his ones, alpha- ubulin, and o he p o eins [ 128 ]. By ac ing on ubulin i has a di ec impac on mic o ubule unc ion. Tubulin can be subjec ed o di e en pos - ansla ional modi ica ions wi h in luence on he mic o ubule polyme iza ion s a e and i s unc ion, such as ace yla ion [ 129 ]. This modi ica ion on he esidue K40 has been epo ed o al e he in e ac ion o p o eins wi h he cy oskele on, wi h subsequen impac on he in acellula anspo along he mic o ubules [ 129 ]. As desc ibed in his wo k, his may a ec mi ochond ia mo phology and dynamics. Pa kinson’s disease has long been linked o inc eased in lamma o y esponse [ 130 ]. In ou analysis we ound ha he p ocesses ela ed o he in lamma o y esponse we e up egula ed: “posi i e egula ion o neu ophil chemo axis” and “ egula ion o complemen ac i a ion”. In e es ingly, om he las p ocess, wo o he implica ed p o eins belong o he P ohibi in amily, which ha e been desc ibed o be in ol ed in he egula ion o mi ochond ial espi a ion [ 131 ]. Rega ding he down egula ion o he p ocess o he “glucoco icoid ecep o signaling pa hway” i is impo an o no e ha a dec ease in he le els o he glucoco icoid ecep o in bo h he SN o pa ien s and in animal models o he disease has been epo ed [ 132 , 133 ]. These ecep o s egula e in lamma ion and a e dys egula ed in mic oglia in he con ex o Pa kinson’s disease. Dys egula ion has been p oposed o sus ain he ch onic in lamma o y s a e obse ed in his diso de as well as he inc eased pe meabili y o he blood b ain ba ie , which migh inc ease neu onal ulne abili y [ 132 , 133 ]. Ano he pa hway ela ed o he in lamma o y p ocess is down egula ed: “posi i e egula ion o NF-kB signaling”, in which he p o ein ibosomal p o ein S3 s ands ou . In e es ingly, his p o ein has been p oposed o p o ec he dopamine gic neu ons om apop osis [134]. Wi hin he ne wo k, he biological p ocesses o “midb ain de elopmen ” and “subs an ia nig a de elopmen ” sha e h ee p o eins: Ac in, Complex I 30 kD om he mi ochond ial espi a o y chain, and he 14-3-3 p o ein epsilon. As desc ibed p e iously, he dys unc ion o Complex I om he mi ochond ial espi a o y chain was he i s indica ion o he mi ochond ia in ol emen in he pa hobiology o Pa kinson’s disease [ 7 , 8 ]. The con ibu ion o he cy oskele on has also been shown, in which ac in has a key ole in he sec e ion o he synap ic esicles con en ha migh be hen ansla ed in o a dec ease in he con en o neu o ansmi e s in he synap ic cle [ 135 ]. Al hough he 14-3-3 p o ein is ubiqui ously exp essed and pa icipa es in he egula ion o many signaling pa hways, i has also been ound o be a cons i uen o he Lewy bodies o Pa kinson’s disease pa ien s [136]. In Pa kinson’s disease he e is a c i ical modi ica ion in he lipid a s composi ion, and inc easing e idence shows hei con ibu ion o he diso de [ 137 – 139 ]. Lipid a s ha e a ole in di e se cellula p ocesses such as memb ane a icking, signal ansduc ion, and cy oskele al o ganiza ion. Thei al e a ion can also ha e a nega i e impac on p o ein-p o ein in e ac ions, which a e undamen al p ocesses o he o ma ion o p o ein supe complexes [ 138 ]. In e es ingly, we ound he p ocess o “memb ane a assembly” o be down egula ed. No only was he p o ein Flo illin-1, a well-known componen o he lipid a s, ound o con ibu e o his node, bu also he p o ein An ioxidan s 2018,7, 1 23 o 45 S100A10. The S100 amily o p o eins a e in ol ed in se e al cellula p ocesses such as he egula ion o cell p oli e a ion and di e en ia ion, apop osis, calcium homeos asis, ene gy me abolism, and in lamma ion. In e es ingly, hey also in e ac wi h cy oskele al and o he cellula p o eins [ 140 ]. Some o he memb ane p o eins ha in e ac wi h he S100A10 a e: Annexin 2, ion channels, ac in binding p o eins, and he se o onin ecep o [ 140 ]. This p o ein has been p oposed o unc ion on memb ane epai and was shown o be down egula ed in dep essi e-like s a es in mice, wi h i s exp ession being egula ed by neu o ophins [141,142]. N-glycosyla ion is a pos - ansla ional modi ica ion ha is ound in memb ane p o eins and sec e ed p o eins; amongs hem a e g ow h ac o s and hei ecep o s [ 143 ]. In ou analysis, we ound ha he p ocess o “p o ein N-linked glycosyla ion ia aspa agine” was down egula ed. This modi ica ion akes places in he ER and in he Golgi, ha ing an e ec on p o ein unc ion. E idence show ha N-glycosyla ion is impo an o p ope neu onal unc ion and has a ole in synap ic ansmission [144], hence ha ing a p o ound impac on he disease [145]. The occu ence o a ole o he ER s ess in he con ex o Pa kinson’s disease [ 146 ] is suppo ed h ough new e idence, and he p ocess o he “ER-nucleus signaling pa hway” was ound o be down egula ed in ou analysis. In his node, we ound he LMNA. Lamins a e ilamen ous p o eins ha con ibu e o he nucleus a chi ec u e and gene exp ession [ 147 , 148 ]. These p o eins also in e ac wi h he ac in cy oskele on, which is known o be a ec ed in Pa kinson’s disease [ 108 , 112 , 113 , 149 ]. The o he p o eins (cal e iculin and he hea shock 70 kDa p o ein 5) a e chape ones in ol ed in p o ein olding and he o ma ion o mul ime ic complexes [ 150 , 151 ], playing a c ucial ole in an oxida i e s ess scena io. Addi ionally, in he case o ission, no only ac in bu also he ER is in ol ed in he p ocess o mi ochond ial p econs uc ion and DRP1 assembly [107]. 4. Discussion Mi ochond ia a e undamen al o ganelles o cells, wo king mainly on ene gy p oduc ion, calcium homeos asis, and apop osis. De ec s in he mi ochond ial espi a o y chain ha e ecei ed much o he a en ion as a key playe in he pa hobiology o Pa kinson’s disease [ 8 , 152 ]. Howe e , addi ional modi ica ions o he mi ochond ia a e being inc easingly epo ed [ 153 , 154 ]. Besides, i is now known ha he inhibi ion o Complex I om he mi ochond ial espi a o y chain by MPP+ and o enone does no di ec ly igge cy och ome c elease bu , ins ead, inc eases he amoun o cy och ome c wi hin he mi ochond ial in e memb ane space [ 155 ], indica ing ha he e a e o he p ocesses equi ed o igge neu onal dea h. Amongs hem a e changes in mi ochond ial dynamics (i.e., al e a ions in he usion and ission p ocesses, al e a ion o c is ae mo phology) [85,156]. Inc easing e idence shows ha o p ope mi ochond ial unc ion, p ocesses like mi ochond ial usion, ission, and u no e a e undamen al, and hei dys unc ion has been linked o di e en diseases [ 1 , 3 ]. In he con ex o Pa kinson’s disease, an inc ease in mi ochond ial ission has been epo ed [ 73 , 157 , 158 ], sugges ing ha his excessi e agmen a ion migh hen enhance cy och ome c elease om mi ochond ia and subsequen ly igge ing apop osis [ 159 ]. Howe e , we ound he p ocess o c is ae emodeling o be mo e highligh ed in ou analysis ega ding he al e a ion o he mi ochond ial-shaping p o eins in Pa kinson’s disease. No ably, he al e a ion o he mi ochond ia c is ae and memb ane migh a ec he p ope binding o cy och ome c, a o ing i s elease o he cy osol and ini ia ing he apop o ic p ocess [ 155 ]. Some e idence o mi ochond ial c is ae emodeling exis s in he con ex o Pa kinson’s disease. One s udy using a cyb id cell line cons uc ed wi h mi ochond ia DNA isola ed om cells om Pa kinson’s disease pa ien s showed ha he e we e de iciencies in bo h complexes o he mi ochond ial espi a o y chain I and IV, and cells con ained a non-homogenous mi ochond ial popula ion wi h di e en mo phologies anging om enla ged o swollen and ounded in shape, which also displayed di e en mi ochond ial memb ane po en ial alues [ 160 ]. A he ul as uc u al le el, some mi ochond ia om his cyb id displayed a dec eased in he ma ix densi y and con ained a educed numbe o c is ae and a discon inuous ou e mi ochond ial memb ane [160]. Simila ly, in a s udy using ansgenic mice o mu a ed α-synuclein, mo phological An ioxidan s 2018,7, 1 24 o 45 al e a ions on he c is ae we e also obse ed, showing a diso de ed inne memb ane and swollen ma ix [ 34 ]. Howe e , his ype o s udy wi h samples om human pa ien s is insu icien , and an inc easing numbe o s udies aiming a deciphe ing he ul as uc u e o he mi ochond ia in Pa kinson’s disease by elec on and supe - esolu ion mic oscopy a e equi ed. I is known ha c is ae emodeling is undamen al du ing apop osis o he p ope elease o cy och ome c [ 27 ], and ha he c is ae a e he si es we e he OXPHOS componen s a e loca ed (94% o Complex II and ATP syn hase [ 161 ], and 85% o cy och ome c [ 27 ]). Compelling da a indica e ha he shape o he c is ae is c ucial o he modula ion o he OXPHOS unc ion [ 18 ], and elies on he cellula s a e [ 162 , 163 ]. Dis up ion o he c is ae junc ions is a esul o he elease o apop o ic ac o s om he mi ochond ia [ 27 ]. Rema kably, in ou analysis mos o he p o eins in ol ed in mi ochond ial dynamics ha we e ound o be al e ed in he con ex o Pa kinson’s disease ha e been p e iously epo ed o play a ole in he mo phology o he c is ae. When imaging mi ochond ia, ou main componen s can be dis inguished a he ul as uc u e le el: he ou e mi ochond ial memb ane (OMM), impo an o egula ing memb ane pe meabili y and he impo /expo o mi ochond ial p o eins; he inne mi ochond ial memb ane (IMM), whe e he mi ochond ial espi a o y chain is placed ( he in agina ions o he IMM in o he ma ix a e he so-called mi ochond ia c is ae); he in e memb ane space (IMS), which is he space be ween he wo mi ochond ial memb anes; and he ma ix, whe e he componen s o he ica boxylic acid (TCA) cycle a e loca ed. The inne mi ochond ial memb ane is o ganized in o h ee specialized zones: he inne bounda y memb ane, whe e he inne and ou e memb anes a e associa ed, con aining p o eins o he p o ein impo machine y; he c is ae, which a e he inne memb ane in agina ions ha a e en iched in p o eins in ol ed in p o ein ansloca ion and syn hesis as well as p o eins in ol ed in i on-sul u biogenesis; and he c is ae junc ions, which a e he po ion o he c is ae ha a e cons ic ed and whe e he MICOS Complex is loca ed [3]. Fundamen al o cell su i al is he implica ion o he mi ochond ia in he egula ion o apop osis. Wi hin his o ganelle se e al p o-apop o ic p o eins eside, igge ing he apop o ic p ocess when eleased in o he cy osol. The pe meabiliza ion o he OMM cons i u es a poin o no e u n in he ac i a ion o his p ocess, whe e he Bcl2 amily o p o eins pa icipa es in i s egula ion [ 164 ]. In e es ingly, ou ne wo k analysis highligh ed he al e a ion on he pe meabili y o memb anes, suppo ing he apop o ic ac i a ion [165]. The OMM mo phology is in luenced by i s in e ac ion wi h he ER, ibosomes, he nucleus, and he cellula cy oskele on [ 3 ]. Fundamen al o he egula ion o mul iple cellula p ocesses a e he mi ochond ial-ER con ac si es [ 164 ]. In ou ne wo k analysis, his in ao ganella in e ac ion was highligh ed as being al e ed in Pa kinson’s disease. Amongs he cellula p ocesses a e: he egula ion o he in acellula calcium le els, mi ochond ial ission, he endowmen o memb anes o phagosomes, and he o ma ion o he in lammasome [ 166 ]. I is now clea how he ER pa icipa es in he ini ia ion o he mi ochond ial ission p ocess. The ER enw aps he mi ochond ia a he cons ic ion si e whe e he dynamin-like p o ein D p1 esponsible o he ission p ocess localizes [ 107 , 167 ]. Addi ionally, ac in polyme iza ion and he ER p o ein in e ed o min 2 (INF2) a e in ol ed in his p ocess [ 38 ]. In e es ingly, ac in ilamen s polyme ized a ound he cons ic ion si es migh cons i u e he pulling o ce o he ission p ocess [ 38 ], and se e al p ocesses ela ed o he ac in cy oskele on we e ound o be al e ed in ou analysis. Addi ionally, he ac in cy oskele on plays a undamen al ole in synap ic esicle sec e ion. The al e a ion o his p ocess a ec s synap ic ansmission in he disease. No only ac in bu also calcium is in ol ed in his p ocess. The egula ion o calcium le els is also dependen on he mi ochond ia-ER c oss alk, and a modi ica ion o i s homeos asis has been epo ed in Pa kinson’s disease [ 168 ]. Mi ochond ial calcium channels display low a ini y o his ion, and o co ec calcium en y in o he mi ochond ia o he o ma ion o he ER-mi ochond ial con ac si es is undamen al [ 169 ]. The ele ance o his in e ac ion has been shown by i s in ol emen in he p og ession o Alzheime ’s disease, whe e i is up egula ed [ 170 ]. When calcium accumula es wi hin he mi ochond ia, oxida i e phospho yla ion An ioxidan s 2018,7, 1 25 o 45 and ATP p oduc ion a e enhanced [ 171 ]. In addi ion, di e en chape ones a e in ol ed in he s abiliza ion o hese con ac si es and could coo dina e signaling be ween mi ochond ia and he ER [ 166 ]. In his di ec ion, we also ound ha he exp ession o he chape one g p78 was al e ed [ 172 ]. The ER-mi ochond ia con ac si es a e also ela ed wi h he ER-s ess esponse, which migh igge apop osis [ 173 ]. This pa hway has also been shown o be ac i e in he con ex o Pa kinson’s disease [ 174 ]. Addi ionally, he calcium eleased by he ER a hese con ac si es migh ac as an ampli ie o he apop o ic pa hway [ 166 ]. Besides, he ission p o ein Fis1 has also been shown o acili a e he clea age o he p o-apop o ic p o ein Bap31 [ 175 ]. In e es ingly, hese con ac si es a e no only ele an o he egula ion o calcium le els, bu also o ROS-media ing signaling [176]. Mo eo e , he ER con ac s wi h he phagosomes and non- unc ional mi ochond ia deg aded by mi ophagy a e ecognized by speci ic OMM p o eins [ 166 ]. MFN2 has also been indica ed as c i ical o au ophagosome o ma ion, and he ER-mi ochond ia in e ac ion is impo an o au ophagosome o ma ion [ 166 , 177 ]. Accumula ing e idence shows ha he ER migh also be in ol ed in he mi ochond ial usion p ocess, since i was shown ha mi o usin2 (MFN2) is necessa y o he e he ing o bo h o ganelles [178]. Rele an o p ope neu onal unc ion is he app op ia e localiza ion o he mi ochond ia wi hin he synap ic e minals, whe e hey can p o ide ATP o exocy osis and egula e calcium le els du ing synap ic ansmission [ 179 ]. Mi ochond ia posi ioning wi hin hese e minals elies no only on mi ochond ial ission [ 180 ], since only small mi ochond ia migh i in o he e minals, bu also in co ec mi ochond ial mo emen along mic o ubules and he ac in cy oskele on [ 164 ]. In his wo k, he ne wo k analysis o cellula componen s and biological pa hways indica ed ha in he con ex o Pa kinson’s disease ac in ilamen s a e a ec ed [ 108 , 112 , 113 ]. In addi ion, dys egula ion o he cellula mic o ubules has been epo ed, namely in he al e a ion o p o eins in ol ed in ubulin ace yla ion. Mos o he d ugs used o induce Pa kinson’s disease modi y mic o ubules, and speci ically, ace yla ion has been shown o a ec he in e ac ion o p o eins wi h he cy oskele on [ 129 ]. Al e a ion o he cellula cy oskele on migh ha e an impac no only on mi ochond ial ission bu also dis ibu ion wi hin neu ons [ 181 – 184 ]. The modi ica ion o he ac in cy oskele on migh also ha e an impac on he egula ion o su ace ecep o dis ibu ion [124], which was highligh ed in he p esen wo k. The ATP p oduced by he mi ochond ia eaches he cy osol by i s ac i e anspo h ough he adenine nucleo ide ansloca o . To p oduce ATP, he p ocesses o he TCA cycle and he espi a o y chain/oxida i e phospho yla ion sys em ac in conjunc ion. The las is loca ed a he IMM. As a esul o he mi ochond ial espi a o y chain de iciency, ATP p oduc ion is educed and ROS a e inc eased, which leads o oxida i e s ess. This inc ease leads o modi ica ions in p o ein, lipids, and DNA wi hin he cells [ 185 ]. Amongs he modi ied lipids, he oxida ion o ca diolipin om he IMM has been epo ed in he con ex o Pa kinson’s disease [ 155 ], and i s oxida ion dis up s he no mal binding o cy och ome c o he memb ane [ 155 ]. Fu he mo e, ER is undamen al o p o iding memb ane lipids o he mi ochond ia [ 186 ], highligh ing again he impo ance o his c oss alk. Phospha idic acid is conside ed a usogenic lipid equi ed o he usion media ed by mi o usins [ 187 ]. Ca diolipin ha e been epo ed o con ol mi ochond ial ission [ 188 , 189 ]. In e es ingly, in he p esen wo k we ound he exp ession o se e al ca diolipin binding p o eins o be modi ied, which migh impac he p ope assembly o he mi ochond ial memb anes. Mo eo e , synap ic mi ochond ia p esen lowe le els o ca diolipin, which has been poin ed ou as a lowe h eshold o he elease o cy och ome c in he apop o ic p ocess [ 164 , 190 ]. I has also been epo ed ha synap ic mi ochond ia p esen highe sensi i i y o he inhibi ion o he mi ochond ial espi a o y chain Complex I [ 191 ]. De achmen o cy och ome c om he memb ane is necessa y o cy och ome c elease o apop o ic ac i a ion and c is ae emodeling [ 27 ]. As discussed abo e, hese undamen al p ocesses ha e been emphasized by he high pe cen age o mi ochond ial-shaping p o eins ound o be al e ed in he con ex o Pa kinson’s disease in con as wi h he p o eins in ol ed in usion and ission. The ER-mi ochond ial connec ion is also impo an o he in lamma o y esponse [ 192 ]. The ac i a ion o he in lammasome migh occu unde an oxida i e s ess scena io, i.e., Pa kinson’s An ioxidan s 2018,7, 1 32 o 45 MIGA1 mi ogua din 1 MIGA2 mi ogua din 2 MINOS1 mi ochond ial inne memb ane o ganizing sys em 1 MINOS2 Mi ochond ial Inne Memb ane O ganizing Sys em 2 MINOS3 Mi ochond ial Inne Memb ane O ganizing Sys em 3 Mi o_shape Mi ochond ial shaping p o eins MITRAC12 Cy och ome c oxidase assembly ac o 3 homolog MPP+ 1-me hyl-4-phenylpy idinium MPRP1 mul id ug esis ance p o ein 1 MPTP 1-me hyl-4-phenyl-1,2,3,6- e ahyd opy idine MT-ATP6 Mi ochond ially Encoded ATP Syn hase 6 MT-ATP8 Mi ochond ially Encoded ATP Syn hase 8 MT-CO1 Mi ochond ially Encoded Cy och ome C Oxidase I MT-CO2 Mi ochond ially Encoded Cy och ome C Oxidase II MT-CO3 Mi ochond ially Encoded Cy och ome C Oxidase III MT-CYB Mi ochond ially Encoded Cy och ome B MTFP1 mi ochond ial ission p ocess 1 m -HSP70 mi ochond ial hea shock p o ein amily A (Hsp70) MTP18 Mi ochond ial ission p ocess p o ein 1 MUL1 mi ochond ial E3 ubiqui in p o ein ligase 1 MULAN Mi ochond ial ubiqui in ligase ac i a o o NFKB 1 My022 ORF name o Mi ochond ial ission p ocess p o ein 1 My025 ORF name o MICOS complex subuni MIC26 My032 ORF name o ATP syn hase subuni d MYL6 myosin ligh chain 6 NAD nico inamide adenine dinucleo ide oxidized NADH nico inamide adenine dinucleo ide educed NBK Bcl-2-in e ac ing kille NDUFA10 NADH:ubiquinone oxido educ ase subuni A10 NDUFA11 NADH:ubiquinone oxido educ ase subuni A11 NDUFA4 NADH Dehyd ogenase (Ubiquinone) 1 Alpha Subcomplex, 4 NDUFS1 NADH:ubiquinone oxido educ ase co e subuni S1 NDUFS3 NADH:ubiquinone oxido educ ase co e subuni S3 NEDD8 neu al p ecu so cell exp essed, de elopmen ally down- egula ed 8 NFE2L2 nuclea ac o , e y h oid 2 like 2 NFKB nuclea ac o kappa-ligh -chain-enhance o ac i a ed B cells NHERF Na(+)/H(+) exchange egula o y co ac o NHE-RF1 NHERF1 Na(+)/H(+) exchange egula o y co ac o NHE-RF1 NHERF-1 p o ein Na(+)/H(+) exchange egula o y co ac o NHE-RF1 NIMA ne e in mi osis gene a NO ni ic oxide Nox1 NADPH oxidase 1 NPM nucleophosmin NPM1 nucleophosmin 1 NRAPGEP Rap guanine nucleo ide exchange ac o 2 NRF1 nuclea espi a o y ac o 1 NRF2 Nuclea ac o e y h oid 2- ela ed ac o 2 OAT o ni hine amino ans e ase OGDH oxoglu a a e dehyd ogenase OIP106 O-linked N-ace ylglucosamine ans e ase in e ac ing p o ein 106 OK/SW-cl.110 ORF name o Phosphoglyce a e kinase 1 OK/SW-cl.56 ORF name o Tubulin be a chain OK/SW-cl.82 ORF name o 40S ibosomal p o ein S15a OMA1 O e lapping Ac i i y Wi h M-AAA P o ease An ioxidan s 2018,7, 1 33 o 45 OMM ou e mi ochond ial memb ane OPA1 Op ic A ophy P o ein 1 OST48 OK/SW-cl.45 synomym o Dolichyl-diphosphooligosaccha ide–p o ein glycosyl ans e ase 48 kDa subuni OTB1 Ubiqui in hioes e ase OTUB1 OTU1 Ubiqui in hioes e ase OTUB1 OTUB1 OTU deubiqui inase, ubiqui in aldehyde binding 1 OXPHOS oxida i e phospho yla ion PARK2 E3 ubiqui in-p o ein ligase pa kin PARL p esenilin associa ed homboid like PD Pa kinson’s disease PD04912 ORF name o Up- egula ed du ing skele al muscle g ow h p o ein 5 PDIA3 p o ein disul ide isome ase amily A membe 3 PDZGEF1 Rap guanine nucleo ide exchange ac o 2 PERC Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-be a PGAM5 Se ine/ h eonine-p o ein phospha ase PGAM5 PGC1 Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-alpha PGC1A Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-alpha PGC1B Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-be a PGK1 phosphoglyce a e kinase 1 PGKA Phosphoglyce a e kinase 1 PGN pa aplegin PHB p ohibi in PHB2 p ohibi in 2 PIG4 ORF name o MICOS complex subuni MIC60 PIG52 ORF name o MICOS complex subuni MIC60 PIN1 pep idylp olyl cis/ ans isome ase, NIMA-in e ac ing 1 PINK1 PTEN-induced pu a i e kinase 1 PLD6 phospholipase D amily membe 6 PP578 ORF name o Endophilin-B2 PPARGC1 Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-alpha PPARGC1A Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-alpha PPARGC1B Pe oxisome p oli e a o -ac i a ed ecep o gamma coac i a o 1-be a PPIA pep idylp olyl isome ase A PRDX4 pe oxi edoxin 4 PRELI P o ein O Rele an E olu iona y And Lymphoid In e es PRELID1 PRELI domain-con aining p o ein 1 PRI synonym o Ribonuclease inhibi o PRKN pa kin RBR E3 ubiqui in p o ein ligase PRO0903 ORF name o Se um albumin PRO1708 ORF name o Se um albumin PRO2044 ORF name o Se um albumin PRO2207 ORF name o P esenilins-associa ed homboid-like p o ein PRO2619 ORF name o Se um albumin PRO2675 ORF name o Se um albumin PSARL P esenilins-associa ed homboid-like p o ein PSC8 P o easome componen C8 PSEC0112 ORF name o Mi ogua din 2 PSMA3 p o easome subuni alpha 3 PTPN5 p o ein y osine phospha ase, non- ecep o ype 5 QIL1 synonym o Ch omosome 19 Open Reading F ame 70 RAB14 Ras- ela ed p o ein Rab-14 RAB2 Ras- ela ed p o ein Rab2 RAB2A Ras- ela ed p o ein Rab-2A An ioxidan s 2018,7, 1 34 o 45 RAC1 Ras- ela ed C3 bo ulinum oxin subs a e 1 RAPGEF2 Rap guanine nucleo ide exchange ac o 2 REA synonym o P ohibi in-2 RHO12 as homolog amily membe RHOA as homolog amily membe A RING- ype E3 eally in e es ing new gene ype E3 RNF153 Ring Finge P o ein 153 RNF218 Ring Finge P o ein 218 RNH Ribonuclease inhibi o RNH1 ibonuclease/angiogenin inhibi o 1 ROMO1 eac i e oxygen species modula o 1 ROS eac i e oxygen species RPN1 Ribopho in I RPN2 ibopho in II RPS15A ibosomal p o ein S15a RPS3, OK/SW-cl.26 symbol and ORF name o 40S ibosomal p o ein S3 S100A10 S100 calcium binding p o ein A10 SAM50 So ing and assembly machine y componen 50 homolog SAMM50 So ing and assembly machine y componen 50 homolog SBBI12 ORF name o PRELI domain-con aining p o ein 1 SBP selenium binding p o ein SELENBP1 selenium binding p o ein 1 SF2P32 nuclea splicing ac o SFXN1 side o lexin 1 SH3 SRC Homology 3 Domain SH3GLB1 SH3 domain con aining GRB2 like, endophilin B1 SH3GLB2 SH3 domain con aining GRB2 like, endophilin B2 SIR2L SIR2-like p o ein SIR2L2 SIR2-like p o ein 2 SIRT2 si uin 2 SLC20A4 solu e ca ie amily 20 membe 4 Slc25A solu e ca ie amily 25 SLC25A10 solu e ca ie amily 25 membe 10 SLC25A11 solu e ca ie amily 25 membe 11 SLC25A12 solu e ca ie amily 25 membe 12 SLC25A13 solu e ca ie amily 25 membe 13 SLC25A18 solu e ca ie amily 25 membe 18 SLC25A38 solu e ca ie amily 25 membe 38 SLC9A3R1 solu e ca ie amily 9 (sodium/hyd ogen exchange ), membe 3 egula o 1 SLP2 S oma in-like p o ein 2 SMAD2 Mo he s agains decapen aplegic homolog 2 SMCR7 Smi h-Magenis Synd ome Ch omosomal Region Candida e Gene 7 P o ein SMCR7L Smi h-Magenis Synd ome Ch omosomal Region Candida e Gene 7 P o ein-like SN Subs an ia nig a SPG7 Pa aplegin SSBP single s anded DNA binding p o ein SSBP1 single s anded DNA binding p o ein 1 STOML2 s oma in like 2 SYNJ2 synap ojanin 2 TAZ a azzin TC25 Ras-Like P o ein TC25 TCA ica boxylic acid cycle TCF6 T ansc ip ion ac o TCF6L2 T ansc ip ion Fac o 6-Like 2 An ioxidan s 2018,7, 1 35 o 45 TCP-1-epsilon T-complex p o ein 1 subuni epsilon TFAM ansc ip ion ac o A, mi ochond ial TIM14 Mi ochond ial Impo Inne Memb ane T anslocase Subuni TIM14 TIMM14 T anslocase O Inne Mi ochond ial Memb ane 14 TMSA T opomyosin alpha-1 chain TMSB opomyosin Be a TPD52 umo p o ein D52 TPM1 opomyosin 1 TPM2 opomyosin 2 TPM3 opomyosin 3 TPM4 opomyosin 4 TRAK1 a icking kinesin p o ein 1 TRAK2 a icking kinesin p o ein 2 TRG3 ans o ma ion- ela ed gene 3 TTC11 e a icopep ide Repea Domain 11 TUBA1A ubulin alpha 1a TUBA3 ubulin alpha-3 chain TUBB ubulin be a class I TUBB2C Tubulin be a-4B chain TUBB4B ubulin be a 4B class IVb TUBB5 Tubulin be a chain TUFM Tu ansla ion elonga ion ac o , mi ochond ial UniP o Uni e sal P o ein Resou ce UNQ1866/PRO4302 ORF name o MICOS complex subuni MIC26 UNQ1868/PRO4304 ORF name o ATP-dependen zinc me allop o ease YME1L1 UNQ655/PRO1286 ORF name o Ubiquinol-cy och ome-c educ ase complex assembly ac o 3 UNQ696/PRO1341 ORF name o Se um albumin UNQ8193/PRO23204 ORF o MICOS complex subuni MIC27 UQBP Ubiquinol-cy och ome c educ ase complex 14 kDa p o ein UQCC3 ubiquinol-cy och ome c educ ase complex assembly ac o 3 UQCR10 Ubiquinol-Cy och ome C Reduc ase, Complex III Subuni X UQCR11 Ubiquinol-Cy och ome C Reduc ase, Complex III Subuni XI UQCRB ubiquinol-cy och ome c educ ase binding p o ein UQCRC1 ubiquinol-cy och ome c educ ase co e p o ein 1 UQCRC2 ubiquinol-cy och ome c educ ase co e p o ein 2 UQCRFS1 ubiquinol-cy och ome c educ ase, Rieske i on-sul u polypep ide 1 UQCRFS1 ubiquinol-cy och ome c educ ase, Rieske i on-sul u polypep ide 1 UQCRFS1P1 ubiquinol-cy och ome c educ ase, Rieske i on-sul u polypep ide 1 pseudogene 1 UQCRFSL1 Ubiquinol-cy och ome c educ ase Rieske i on-sul u subuni pseudogene 1 UQCRH ubiquinol-cy och ome c educ ase hinge p o ein UQCRQ ubiquinol-cy och ome c educ ase complex ubiquinone-binding p o ein QP-C USMG5 Up- egula ed du ing skele al muscle g ow h p o ein 5 VAT1 esicle amine anspo 1 VCP alosin con aining p o ein VDAC1 Vol age-dependen anion-selec i e channel p o ein 1 VDAC2 ol age dependen anion channel 2 VDAC3 ol age dependen anion channel 3 VDAC Vol age-dependen anion-selec i e channel VIM imen in VISA Vi us-induced-signaling adap e YME1L YME1-like p o ein 1 YME1L1 YME1-like p o ein 1 YWHAE y osine 3-monooxygenase/ yp ophan 5-monooxygenase ac i a ion p o ein epsilon YWHAZ y osine 3-monooxygenase/ yp ophan 5-monooxygenase ac i a ion p o ein ze a An ioxidan s 2018,7, 1 36 o 45 Re e ences 1. Kasaha a, A.; Sco ano, L. Mi ochond ia: F om cell dea h execu ione s o egula o s o cell di e en ia ion. T ends Cell Biol. 2014,24, 761–770. [C ossRe ] [PubMed] 2. Anes i, V.; Sco ano, L. The ela ionship be ween mi ochond ial shape and unc ion and he cy oskele on. Biochim. Biophys. Ac a 2006,1757, 692–699. [C ossRe ] [PubMed] 3. Pe nas, L.; Sco ano, L. Mi o-mo phosis: Mi ochond ial usion, ission, and c is ae emodeling as key media o s o cellula unc ion. Annu. Re . Physiol. 2016,78, 505–531. [C ossRe ] [PubMed] 4. Gao, J.; Wang, L.; Liu, J.; Xie, F.; Su, B.; Wang, X. Abno mali ies o mi ochond ial dynamics in neu odegene a i e diseases. An ioxidan s 2017,6, 25. [C ossRe ] [PubMed] 5. Muangpaisan, W.; Ma hews, A.; Ho i, H.; Seidel, D. A sys ema ic e iew o he wo ldwide p e alence and incidence o Pa kinson’s disease. J. Med. Assoc. Thail. 2011,94, 749–755. 6. An ony, P.M.; Diede ich, N.J.; K uge , R.; Balling, R. The hallma ks o Pa kinson’s disease. FEBS J. 2013 ,280, 5981–5993. [C ossRe ] [PubMed] 7. Schapi a, A.H.; Coope , J.M.; Dex e , D.; Jenne , P.; Cla k, J.B.; Ma sden, C.D. Mi ochond ial complex I de iciency in Pa kinson’s disease. Lance 1989,1, 1269. [C ossRe ] 8. Schapi a, A.H.; Coope , J.M.; Dex e , D.; Cla k, J.B.; Jenne , P.; Ma sden, C.D. Mi ochond ial complex I de iciency in Pa kinson’s disease. J. Neu ochem. 1990,54, 823–827. [C ossRe ] [PubMed] 9. Hayle , W.; Swa , C.; an de Wes huizen, F.; an Dyk, H.; an de Me we, L.; an de Me we, C.; Loos, B.; Ca , J.; Kinnea , C.; Ba dien, S. Al e ed mi ochond ial espi a ion and o he ea u es o mi ochond ial unc ion in pa kin-mu an ib oblas s om Pa kinson’s disease pa ien s. Pa kinson’s Dis. 2016 ,2016, 1819209. 10. Hao, L.Y.; Giasson, B.I.; Bonini, N.M. Dj-1 is c i ical o mi ochond ial unc ion and escues pink1 loss o unc ion. P oc. Na l. Acad. Sci. USA 2010,107, 9747–9752. [C ossRe ] [PubMed] 11. Ahmad, T.; Agga wal, K.; Pa naik, B.; Mukhe jee, S.; Se hi, T.; Tiwa i, B.K.; Kuma , M.; Micheal, A.; Mabali ajan, U.; Ghosh, B.; e al. Compu a ional classi ica ion o mi ochond ial shapes e lec s s ess and edox s a e. Cell Dea h Dis. 2013,4, e461. [C ossRe ] [PubMed] 12. Haddad, D.; Nakamu a, K. Unde s anding he suscep ibili y o dopamine neu ons o mi ochond ial s esso s in Pa kinson’s disease. FEBS Le . 2015,589, 3702–3713. [C ossRe ] [PubMed] 13. Apweile , R.; Bai och, A.; Wu, C.H.; Ba ke , W.C.; Boeckmann, B.; Fe o, S.; Gas eige , E.; Huang, H.; Lopez, R.; Mag ane, M.; e al. Unip o : The uni e sal p o ein knowledgebase. Nucleic Acids Res. 2017 ,45, D158–D169. [C ossRe ] [PubMed] 14. F iedman, J.R.; Mou ie , A.; Yamada, J.; McCa e y, J.M.; Nunna i, J. MICOS coo dina es wi h espi a o y complexes and lipids o es ablish inne mi ochond ial memb ane a chi ec u e. eLi e 2015 ,4. [C ossRe ] [PubMed] 15. Ikon, N.; Ryan, R.O. Ca diolipin and mi ochond ial c is ae o ganiza ion. Biochim. Biophys. Ac a 2017 ,1859, 1156–1163. [C ossRe ] [PubMed] 16. Koob, S.; Ba e a, M.; Anand, R.; Reiche , A.S. The non-glycosyla ed iso o m o MIC26 is a cons i uen o he mammalian MICOS complex and p omo es o ma ion o c is a junc ions. Biochimi. Biophys. Ac a 2015 , 1853, 1551–1563. [C ossRe ] [PubMed] 17. Wilkens, V.; Kohl, W.; Busch, K. Res ic ed di usion o OXPHOS complexes in dynamic mi ochond ia delays hei exchange be ween c is ae and engende s a ansi o y mosaic dis ibu ion. J. Cell Sci. 2013 ,126, 103–116. [C ossRe ] [PubMed] 18. Coglia i, S.; En iquez, J.A.; Sco ano, L. Mi ochond ial c is ae: Whe e beau y mee s unc ionali y. T ends Biochem. Sci. 2016,41, 261–273. [C ossRe ] [PubMed] 19. an de Bliek, A.M.; Shen, Q.; Kawaji i, S. Mechanisms o mi ochond ial ission and usion. Cold Sp ing Ha b. Pe spec . Biol. 2013,5, a011072. [C ossRe ] [PubMed] 20. Faccenda, D.; Tan, C.H.; Se aphim, A.; Duchen, M.R.; Campanella, M. IF1 limi s he apop o ic-signalling cascade by p e en ing mi ochond ial emodelling. Cell Dea h Di e . 2013 ,20, 686–697. [C ossRe ] [PubMed] 21. Luna-Va gas, M.P.; Chipuk, J.E. Physiological and pha macological con ol o BAK, BAX, and beyond. T ends Cell Biol. 2016,26, 906–917. [C ossRe ] [PubMed] 22. Campello, S.; Sco ano, L. Mi ochond ial shape changes: O ches a ing cell pa hophysiology. EMBO Rep. 2010,11, 678–684. [C ossRe ] [PubMed] An ioxidan s 2018,7, 1 37 o 45 23. Sco ano, L. Opening he doo s o cy och ome c: Changes in mi ochond ial shape and apop osis. In . J. Biochem. Cell Biol. 2009,41, 1875–1883. [C ossRe ] [PubMed] 24. Vale o, J.G.; Co nu -Thibau , A.; Juge, R.; Debaud, A.L.; Gimenez, D.; Gille , G.; Bonne oy-Be a d, N.; Salgado, J.; Salles, G.; Aouache ia, A.; e al. Mic o-calpain con e sion o an iapop o ic B l-1 (BCL2A1) in o a p odea h ac o e eals wo dis inc alpha-helices inducing mi ochond ia-media ed apop osis. PLoS ONE 2012,7, e38620. [C ossRe ] [PubMed] 25. Wasilewski, M.; Sco ano, L. The changing shape o mi ochond ial apop osis. T ends Endoc inol. Me ab. 2009 , 20, 287–294. [C ossRe ] [PubMed] 26. Yamaguchi, R.; La igue, L.; Pe kins, G.; Sco , R.T.; Dixi , A.; Kushna e a, Y.; Kuwana, T.; Ellisman, M.H.; Newmeye , D.D. Opa1-media ed c is ae opening is Bax/Bak and BH3 dependen , equi ed o apop osis, and independen o Bak oligome iza ion. Mol. Cell 2008,31, 557–569. [C ossRe ] [PubMed] 27. Sco ano, L.; Ashiya, M.; Bu le, K.; Weile , S.; Oakes, S.A.; Mannella, C.A.; Ko smeye , S.J. A dis inc pa hway emodels mi ochond ial c is ae and mobilizes cy och ome cdu ing apop osis. De . Cell 2002 ,2, 55–67. [C ossRe ] 28. Ge main, M.; Ma hai, J.P.; McB ide, H.M.; Sho e, G.C. Endoplasmic e iculum Bik ini ia es DRP1- egula ed emodelling o mi ochond ial c is ae du ing apop osis. EMBO J. 2005 ,24, 1546–1556. [C ossRe ] [PubMed] 29. Ong, S.B.; Kalkho an, S.B.; He nandez-Resendiz, S.; Samangouei, P.; Ong, S.G.; Hausenloy, D.J. Mi ochond ial-shaping p o eins in ca diac heal h and disease—The long and he sho o i ! Ca dio asc. D ugs The . Spons. In . Soc. Ca dio asc. Pha maco he . 2017,31, 87–107. [C ossRe ] [PubMed] 30. Ban-Ishiha a, R.; Tomohi o-Takamiya, S.; Tani, M.; Baudie , J.; Ishiha a, N.; Kuge, O. COX assembly ac o ccdc56 egula es mi ochond ial mo phology by a ec ing mi ochond ial ec ui men o D p1. FEBS Le . 2015 , 589, 3126–3132. [C ossRe ] [PubMed] 31. Rich e -Denne lein, R.; Ko wi z, A.; Haag, M.; Ta su a, T.; Da gazanli, S.; Bake , M.; Decke , T.; Lamkemeye , T.; Ruga li, E.I.; Lange , T. DNAJC19, a mi ochond ial cochape one associa ed wi h ca diomyopa hy, o ms a complex wi h p ohibi ins o egula e ca diolipin emodeling. Cell Me ab. 2014 ,20, 158–171. [C ossRe ] [PubMed] 32. Da ey, K.M.; Pa boosingh, J.S.; McLeod, D.R.; Chan, A.; Casey, R.; Fe ei a, P.; Snyde , F.F.; B idge, P.J.; Be nie , F.P. Mu a ion o DNAJC19, a human homologue o yeas inne mi ochond ial memb ane co-chape ones, causes DCMA synd ome, a no el au osomal ecessi e Ba h synd ome-like condi ion. J. Med. Gene . 2006,43, 385–393. [C ossRe ] [PubMed] 33. Lee, J.E.; Wes a e, L.M.; Wu, H.; Page, C.; Voel z, G.K. Mul iple dynamin amily membe s collabo a e o d i e mi ochond ial di ision. Na u e 2016,540, 139–143. [C ossRe ] [PubMed] 34. Chen, M.; Chen, Z.; Wang, Y.; Tan, Z.; Zhu, C.; Li, Y.; Han, Z.; Chen, L.; Gao, R.; Liu, L.; e al. Mi ophagy ecep o FUNDC1 egula es mi ochond ial dynamics and mi ophagy. Au ophagy 2016 ,12, 689–702. [C ossRe ] [PubMed] 35. Liu, L.; Feng, D.; Chen, G.; Chen, M.; Zheng, Q.; Song, P.; Ma, Q.; Zhu, C.; Wang, R.; Qi, W.; e al. Mi ochond ial ou e -memb ane p o ein FUNDC1 media es hypoxia-induced mi ophagy in mammalian cells. Na . Cell Biol. 2012,14, 177–185. [C ossRe ] [PubMed] 36. Gomes, L.C.; Sco ano, L. Mi ochond ial mo phology in mi ophagy and mac oau ophagy. Biochim. Biophys. Ac a 2013,1833, 205–212. [C ossRe ] [PubMed] 37. John, G.B.; Shang, Y.; Li, L.; Renken, C.; Mannella, C.A.; Selke , J.M.; Rangell, L.; Benne , M.J.; Zha, J. The inne mi ochond ial memb ane p o ein mi o ilin con ols c is ae mo phology. Mol. Biol. Cell 2005 ,16, 1543–1554. [C ossRe ] [PubMed] 38. Ko obo a, F.; Ramabhad an, V.; Higgs, H.N. An ac in-dependen s ep in mi ochond ial ission media ed by he ER-associa ed o min INF2. Science 2013,339, 464–467. [C ossRe ] [PubMed] 39. Dimme , K.S.; Na oni, F.; Casa in, A.; T e isson, E.; Endele, S.; Win e pach , A.; Sal ia i, L.; Sco ano, L. LETM1, dele ed in Wol -Hi schho n synd ome is equi ed o no mal mi ochond ial mo phology and cellula iabili y. Hum. Mol. Gene . 2008,17, 201–214. [C ossRe ] [PubMed] 40. Koshiba, T. Mi ochond ial-media ed an i i al immuni y. Biochim. Biophys. Ac a 2013 ,1833, 225–232. [C ossRe ] [PubMed] 41. Pe cia alle, R.M.; S ewa , D.P.; Koss, B.; Lynch, J.; Milas a, S.; Ba hina, M.; Temi o , J.; Cleland, M.M.; Pelle ie , S.; Schue z, J.D.; e al. An i-apop o ic MCL-1 localizes o he mi ochond ial ma ix and couples mi ochond ial usion o espi a ion. Na . Cell Biol. 2012,14, 575–583. [C ossRe ] [PubMed] An ioxidan s 2018,7, 1 38 o 45 42. Mo ciano, G.; Gio gi, C.; Bales a, D.; Ma chi, S.; Pe one, D.; Pino i, M.; Pin on, P. MCL-1 in ol emen in mi ochond ial dynamics is associa ed wi h apop o ic cell dea h. Mol. Biol. Cell 2016 ,27, 20–34. [C ossRe ] [PubMed] 43. Chen, H.; De me , S.A.; Ewald, A.J.; G i in, E.E.; F ase , S.E.; Chan, D.C. Mi o usins M n1 and M n2 coo dina ely egula e mi ochond ial usion and a e essen ial o emb yonic de elopmen . J. Cell Biol. 2003 , 160, 189–200. [C ossRe ] [PubMed] 44. Zhang, Y.; Liu, X.; Bai, J.; Tian, X.; Zhao, X.; Liu, W.; Duan, X.; Shang, W.; Fan, H.Y.; Tong, C. Mi ogua din egula es mi ochond ial usion h ough mi opld and is equi ed o neu onal homeos asis. Mol. Cell 2016 ,61, 111–124. [C ossRe ] [PubMed] 45. Wai, T.; Lange , T. Mi ochond ial dynamics and me abolic egula ion. T ends Endoc inol. Me ab. 2016 ,27, 105–117. [C ossRe ] [PubMed] 46. Yin, X.; Manczak, M.; Reddy, P.H. Mi ochond ia- a ge ed molecules Mi oQ and SS31 educe mu an hun ing in-induced mi ochond ial oxici y and synap ic damage in Hun ing on’s disease. Hum. Mol. Gene . 2016,25, 1739–1753. [C ossRe ] [PubMed] 47. Dinko a-Kos o a, A.T.; Ab amo , A.Y. The eme ging ole o N 2 in mi ochond ial unc ion. F ee Radic. Biol. Med. 2015,88, 179–188. [C ossRe ] [PubMed] 48. Be ei e -Hahn, J.; Jend ach, M. Mi ochond ial dynamics. In . Re . Cell Mol. Biol. 2010,284, 1–65. [PubMed] 49. Dab owska, A.; Vene o, J.L.; Iwasawa, R.; Hanki , M.K.; Rahman, S.; Boobis, A.; Hajji, N. PGC-1alpha con ols mi ochond ial biogenesis and dynamics in lead-induced neu o oxici y. Aging 2015 ,7, 629–647. [C ossRe ] [PubMed] 50. Pa en, D.A.; Wong, J.; Khacho, M.; Soubannie , V.; Mailloux, R.J.; Pilon-La ose, K.; MacLau in, J.G.; Pa k, D.S.; McB ide, H.M.; T inkle-Mulcahy, L.; e al. Opa1-dependen c is ae modula ion is essen ial o cellula adap a ion o me abolic demand. EMBO J. 2014,33, 2676–2691. [C ossRe ] [PubMed] 51. Hall, A.R.; Bu ke, N.; Dongwo h, R.K.; Hausenloy, D.J. Mi ochond ial usion and ission p o eins: No el he apeu ic a ge s o comba ing ca dio ascula disease. B . J. Pha macol. 2014 ,171, 1890–1906. [C ossRe ] [PubMed] 52. Wang, Z.; Jiang, H.; Chen, S.; Du, F.; Wang, X. The mi ochond ial phospha ase PGAM5 unc ions a he con e gence poin o mul iple nec o ic dea h pa hways. Cell 2012,148, 228–243. [C ossRe ] [PubMed] 53. Me kwi h, C.; Da gazanli, S.; Ta su a, T.; Geime , S.; Lowe , B.; Wunde lich, F.T.; on Kleis -Re zow, J.C.; Waisman, A.; Wes e mann, B.; Lange , T. P ohibi ins con ol cell p oli e a ion and apop osis by egula ing opa1-dependen c is ae mo phogenesis in mi ochond ia. Genes De . 2008 ,22, 476–488. [C ossRe ] [PubMed] 54. Buhlman, L.; Damiano, M.; Be olin, G.; Fe ando-Miguel, R.; Lombes, A.; B ice, A.; Co i, O. Func ional in e play be ween pa kin and D p1 in mi ochond ial ission and clea ance. Biochim. Biophys. Ac a 2014 ,1843, 2012–2026. [C ossRe ] [PubMed] 55. LeBleu, V.S.; O’Connell, J.T.; Gonzalez He e a, K.N.; Wikman, H.; Pan el, K.; Haigis, M.C.; de Ca alho, F.M.; Damascena, A.; Domingos Chinen, L.T.; Rocha, R.M.; e al. PGC-1alpha media es mi ochond ial biogenesis and oxida i e phospho yla ion in cance cells o p omo e me as asis. Na . Cell Biol. 2014 ,16, 992–1003. [C ossRe ] [PubMed] 56. Shao, D.; Liu, Y.; Liu, X.; Zhu, L.; Cui, Y.; Cui, A.; Qiao, A.; Kong, X.; Chen, Q.; Gup a, N.; e al. PGC-1 be a- egula ed mi ochond ial biogenesis and unc ion in myo ubes is media ed by N -1 and ERR alpha. Mi ochond ion 2010,10, 516–527. [C ossRe ] [PubMed] 57. Sesaki, H.; Dunn, C.D.; Iijima, M.; Shepa d, K.A.; Ya e, M.P.; Machame , C.E.; Jensen, R.E. Ups1p, a conse ed in e memb ane space p o ein, egula es mi ochond ial shape and al e na i e opogenesis o Mgm1p. J. Cell Biol. 2006,173, 651–658. [C ossRe ] [PubMed] 58. Ha mann, B.; Wai, T.; Hu, H.; MacVica , T.; Musan e, L.; Fische -Zi nsak, B.; S enzel, W.; G a , R.; an den Heu el, L.; Rope s, H.H.; e al. Homozygous YME1L1 mu a ion causes mi ochond iopa hy wi h op ic a ophy and mi ochond ial ne wo k agmen a ion. eLi e 2016,5, e16078. [C ossRe ] [PubMed] 59. Gomes, L.C.; Di Benede o, G.; Sco ano, L. Du ing au ophagy mi ochond ia elonga e, a e spa ed om deg ada ion and sus ain cell iabili y. Na . Cell Biol. 2011,13, 589–598. [C ossRe ] [PubMed] 60. Shal ouki, A.; Si apa ham, R.; Pei, Y.; Ge encse , A.A.; Momcilo ic, O.; Rao, M.S.; Zeng, X. Mi ochond ial al e a ions by PARKIN in dopamine gic neu ons using PARK2 pa ien -speci ic and PARK2 knockou isogenic IPSC lines. S em Cell Rep. 2015,4, 847–859. [C ossRe ] [PubMed] An ioxidan s 2018,7, 1 39 o 45 61. No on, M.; Ng, A.C.; Bai d, S.; Dumoulin, A.; Shu , T.; Mah, N.; And ade-Na a o, M.A.; McB ide, H.M.; Sc ea on, R.A. ROMO1 is an essen ial edox-dependen egula o o mi ochond ial dynamics. Sci. Signal. 2014,7, a10. [C ossRe ] [PubMed] 62. Ka bowski, M.; Jeong, S.Y.; Youle, R.J. Endophilin B1 is equi ed o he main enance o mi ochond ial mo phology. J. Cell Biol. 2004,166, 1027–1039. [C ossRe ] [PubMed] 63. Wang, Y.H.; Wang, J.Q.; Wang, Q.; Wang, Y.; Guo, C.; Chen, Q.; Chai, T.; Tang, T.S. Endophilin B2 p omo es inne mi ochond ial memb ane deg ada ion by o ming he e odime s wi h endophilin B1 du ing mi ophagy. Sci. Rep. 2016,6, 25153. [C ossRe ] [PubMed] 64. Zhang, C.; Shi, Z.; Zhang, L.; Zhou, Z.; Zheng, X.; Liu, G.; Bu, G.; F ase , P.E.; Xu, H.; Zhang, Y.W. Appop osin in e ac s wi h mi ochond ial ou e -memb ane usion p o eins and egula es mi ochond ial mo phology. J. Cell Sci. 2016,129, 994–1002. [C ossRe ] [PubMed] 65. Kuma , S.; Pan, C.C.; Shah, N.; Wheele , S.E.; Hoy , K.R.; Hempel, N.; My h eye, K.; Lee, N.Y. Ac i a ion o mi o usin2 by smad2-RIN1 complex du ing mi ochond ial usion. Mol. Cell 2016 ,62, 520–531. [C ossRe ] [PubMed] 66. Nemo o, Y.; De Camilli, P. Rec ui men o an al e na i ely spliced o m o synap ojanin 2 o mi ochond ia by he in e ac ion wi h he PDZ domain o a ou e mi ochond ial memb ane p o ein. EMBO J. 1999 ,18, 2991–3006. [C ossRe ] [PubMed] 67. Gonzal ez, F.; D’Au elio, M.; Bou an , M.; Mous apha, A.; Puech, J.P.; Landes, T.; A naune-Pelloquin, L.; Vial, G.; Taleux, N.; Slomianny, C.; e al. Ba h synd ome: Cellula compensa ion o mi ochond ial dys unc ion and apop osis inhibi ion due o changes in ca diolipin emodeling linked o a azzin (TAZ) gene mu a ion. Biochim. Biophys. Ac a 2013,1832, 1194–1206. [C ossRe ] [PubMed] 68. Acehan, D.; Xu, Y.; S okes, D.L.; Schlame, M. Compa ison o lymphoblas mi ochond ia om no mal subjec s and pa ien s wi h ba h synd ome using elec on mic oscopic omog aphy. Lab. In es ig. J. Tech. Me hods Pa hol. 2007,87, 40–48. [C ossRe ] [PubMed] 69. Desmu s, M.; Fo i, M.; Raemy, E.; Vaz, F.M.; Ma inou, J.C.; Bai och, A.; Lane, L. C11o 83, a mi ochond ial ca diolipin-binding p o ein in ol ed in bc1 complex assembly and supe complex s abiliza ion. Mol. Cell. Biol. 2015,35, 1139–1156. [C ossRe ] [PubMed] 70. Eu a, Y.; Ishiha a, N.; Oka, T.; Miha a, K. Iden i ica ion o a no el p o ein ha egula es mi ochond ial usion by modula ing mi o usin (M n) p o ein unc ion. J. Cell Sci. 2006,119, 4913–4925. [C ossRe ] [PubMed] 71. Oli e os, J.C. Venny. An In e ac i e Tool o Compa ing Lis s wi h Venn’s Diag ams. A ailable online: h p://bioin ogp.cnb.csic.es/ ools/ enny/index.h ml (accessed on 29 Augus 2017). 72. Alanis-Loba o, G.; And ade-Na a o, M.A.; Schae e , M.H. Hippie 2.0: Enhancing meaning ulness and eliabili y o p o ein-p o ein in e ac ion ne wo ks. Nucleic Acids Res. 2017 ,45, D408–D414. [C ossRe ] [PubMed] 73. Gomez-Laza o, M.; Bonekamp, N.A.; Galindo, M.F.; Jo dan, J.; Sch ade , M. 6-hyd oxydopamine (6-OHDA) induces D p1-dependen mi ochond ial agmen a ion in SH-SY5Y cells. F ee Radic. Biol. Med. 2008 ,44, 1960–1969. [C ossRe ] [PubMed] 74. Yang, Y.; Lu, B. Mi ochond ial mo phogenesis, dis ibu ion, and Pa kinson disease: Insigh s om pink1. J. Neu opa hol. Exp. Neu ol. 2009,68, 953–963. [C ossRe ] [PubMed] 75. Winklho e , K.F.; Haass, C. Mi ochond ial dys unc ion in Pa kinson’s disease. Biochim. Biophys. Ac a 2010 , 1802, 29–44. [C ossRe ] [PubMed] 76. Wieme slage, L.; Ismael, S.; Lee, D. Ea ly al e a ions o mi ochond ial mo phology in dopamine gic neu ons om Pa kinson’s disease-like pa hology and ime-dependen neu op o ec ion wi h D2 ecep o ac i a ion. Mi ochond ion 2016,30, 138–147. [C ossRe ] [PubMed] 77. Van Laa , V.S.; Be man, S.B. Mi ochond ial dynamics in Pa kinson’s disease. Exp. Neu ol. 2009 ,218, 247–256. [C ossRe ] [PubMed] 78. Lee, H.J.; Khoshaghideh, F.; Lee, S.; Lee, S.J. Impai men o mic o ubule-dependen a icking by o e exp ession o alpha-synuclein. Eu . J. Neu osci. 2006,24, 3153–3162. [C ossRe ] [PubMed] 79. Gilla don, F. Leucine- ich epea kinase 2 phospho yla es b ain ubulin-be a iso o ms and modula es mic o ubule s abili y—A poin o con e gence in Pa kinsonian neu odegene a ion? J. Neu ochem. 2009 ,110, 1514–1522. [C ossRe ] [PubMed] An ioxidan s 2018,7, 1 40 o 45 80. Lu z, A.K.; Exne , N.; Fe , M.E.; Schlehe, J.S.; Kloos, K.; Lamme mann, K.; B unne , B.; Ku z-D exle , A.; Vogel, F.; Reiche , A.S.; e al. Loss o pa kin o PINK1 unc ion inc eases D p1-dependen mi ochond ial agmen a ion. J. Biol. Chem. 2009,284, 22938–22951. [C ossRe ] [PubMed] 81. Sandeb ing, A.; Thomas, K.J.; Beilina, A.; an de B ug, M.; Cleland, M.M.; Ahmad, R.; Mille , D.W.; Zamb ano, I.; Cowbu n, R.F.; Behbahani, H.; e al. Mi ochond ial al e a ions in PINK1 de icien cells a e in luenced by calcineu in-dependen dephospho yla ion o dynamin- ela ed p o ein 1. PLoS ONE 2009 ,4, e5701. [C ossRe ] [PubMed] 82. Dagda, R.K.; Gusdon, A.M.; Pien, I.; S ack, S.; G een, S.; Li, C.; Van Hou en, B.; Che a, S.J., 3 d; Chu, C.T. Mi ochond ially localized PKA e e ses mi ochond ial pa hology and dys unc ion in a cellula model o Pa kinson’s disease. Cell Dea h Di e . 2011,18, 1914–1923. [C ossRe ] [PubMed] 83. Van Laa , V.S.; A nold, B.; Cassady, S.J.; Chu, C.T.; Bu on, E.A.; Be man, S.B. Bioene ge ics o neu ons inhibi he ansloca ion esponse o pa kin ollowing apid mi ochond ial depola iza ion. Hum. Mol. Gene . 2011 , 20, 927–940. [C ossRe ] [PubMed] 84. Chen, Y.; Cso das, G.; Jowdy, C.; Schneide , T.G.; Cso das, N.; Wang, W.; Liu, Y.; Kohlhaas, M.; Meise , M.; Be gem, S.; e al. Mi o usin 2-con aining mi ochond ial- e icula mic odomains di ec apid ca diomyocy e bioene ge ic esponses ia in e o ganelle Ca(2+) c oss alk. Ci c. Res. 2012 ,111, 863–875. [C ossRe ] [PubMed] 85. Zuchne , S.; Me siyano a, I.V.; Muglia, M.; Bissa -Tadmou i, N.; Rochelle, J.; Dadali, E.L.; Zappia, M.; Nelis, E.; Pa i ucci, A.; Sende ek, J.; e al. Mu a ions in he mi ochond ial GTPase mi o usin 2 cause cha co -ma ie- oo h neu opa hy ype 2A. Na . Gene . 2004,36, 449–451. [C ossRe ] [PubMed] 86. Hoeks a, J.G.; Cook, T.J.; S ewa , T.; Ma ison, H.; D eisbach, M.T.; Ho e , Z.S.; Zhang, J. As ocy ic dynamin-like p o ein 1 egula es neu onal p o ec ion agains exci o oxici y in Pa kinson disease. Am. J. Pa hol. 2015,185, 536–549. [C ossRe ] [PubMed] 87. Jin, J.; Hule e, C.; Wang, Y.; Zhang, T.; Pan, C.; Wadhwa, R.; Zhang, J. P o eomic iden i ica ion o a s ess p o ein, mo alin/m hsp70/GRP75: Rele ance o Pa kinson disease. Mol. Cell. P o eom. 2006 ,5, 1193–1204. [C ossRe ] [PubMed] 88. Jakobs, S.; Wu m, C.A. Supe - esolu ion mic oscopy o mi ochond ia. Cu . Opin. Chem. Biol. 2014 ,20, 9–15. [C ossRe ] [PubMed] 89. Jans, D.C.; Wu m, C.A.; Riedel, D.; Wenzel, D.; S agge, F.; Decke s, M.; Rehling, P.; Jakobs, S. S ed supe - esolu ion mic oscopy e eals an a ay o minos clus e s along human mi ochond ia. P oc. Na l. Acad. Sci. USA 2013,110, 8936–8941. [C ossRe ] [PubMed] 90. P anne , N.; an de Laan, M.; Ama i, P.; Capaldi, R.A.; Caudy, A.A.; Chacinska, A.; Da shi, M.; Decke s, M.; Hoppins, S.; Icho, T.; e al. Uni o m nomencla u e o he mi ochond ial con ac si e and c is ae o ganizing sys em. J. Cell Biol. 2014,204, 1083–1086. [C ossRe ] [PubMed] 91. O , C.; Ross, K.; S aub, S.; Thiede, B.; Go z, M.; Goosmann, C.; K ischke, M.; Muelle , M.J.; K ohne, G.; Rudel, T.; e al. Sam50 unc ions in mi ochond ial in e memb ane space b idging and biogenesis o espi a o y complexes. Mol. Cell. Biol. 2012,32, 1173–1188. [C ossRe ] [PubMed] 92. Tonde a, D.; G andemange, S.; Jou dain, A.; Ka bowski, M.; Ma enbe ge , Y.; He zig, S.; Da C uz, S.; Cle c, P.; Raschke, I.; Me kwi h, C.; e al. SLP-2 is equi ed o s ess-induced mi ochond ial hype usion. EMBO J. 2009,28, 1589–1600. [C ossRe ] [PubMed] 93. S eglich, G.; Neupe , W.; Lange , T. P ohibi ins egula e memb ane p o ein deg ada ion by he m-AAA p o ease in mi ochond ia. Mol. Cell. Biol. 1999,19, 3435–3442. [C ossRe ] [PubMed] 94. Nij mans, L.G.; de Jong, L.; A al Sanz, M.; Coa es, P.J.; Be den, J.A.; Back, J.W.; Muijse s, A.O.; an de Spek, H.; G i ell, L.A. P ohibi ins ac as a memb ane-bound chape one o he s abiliza ion o mi ochond ial p o eins. EMBO J. 2000,19, 2444–2451. [C ossRe ] [PubMed] 95. Pauma d, P.; Vaillie , J.; Coula y, B.; Schae e , J.; Soubannie , V.; Muelle , D.M.; B e hes, D.; di Rago, J.P.; Velou s, J. The ATP syn hase is in ol ed in gene a ing mi ochond ial c is ae mo phology. EMBO J. 2002 ,21, 221–230. [C ossRe ] [PubMed] 96. Habe se ze , J.; La ieu, I.; P iaul , M.; Salin, B.; Rossignol, R.; B e hes, D.; Pauma d, P. Human F1F0 ATP syn hase, mi ochond ial ul as uc u e and OXPHOS impai men : A (supe -) complex ma e ? PLoS ONE 2013,8, e75429. [C ossRe ] [PubMed] 97. S auss, M.; Ho haus, G.; Sch ode , R.R.; Kuhlb and , W. Dime ibbons o ATP syn hase shape he inne mi ochond ial memb ane. EMBO J. 2008,27, 1154–1160. [C ossRe ] [PubMed] An ioxidan s 2018,7, 1 41 o 45 98. Ce eghe i, G.M.; S anghe lin, A.; Ma ins de B i o, O.; Chang, C.R.; Blacks one, C.; Be na di, P.; Sco ano, L. Dephospho yla ion by calcineu in egula es ansloca ion o D p1 o mi ochond ia. P oc. Na l. Acad. Sci. USA 2008,105, 15803–15808. [C ossRe ] [PubMed] 99. Schae e , M.H.; Fon aine, J.F.; Vinayagam, A.; Po as, P.; Wanke , E.E.; And ade-Na a o, M.A. Hippie: In eg a ing p o ein in e ac ion ne wo ks wi h expe imen based quali y sco es. PLoS ONE 2012 ,7, e31826. [C ossRe ] [PubMed] 100. Schae e , M.H.; Lopes, T.J.; Mah, N.; Shoemake , J.E.; Ma suoka, Y.; Fon aine, J.F.; Louis-Jeune, C.; Eis eld, A.J.; Neumann, G.; Pe ez-I a xe a, C.; e al. Adding p o ein con ex o he human p o ein-p o ein in e ac ion ne wo k o e eal meaning ul in e ac ions. PLoS Compu . Biol. 2013,9, e1002860. [C ossRe ] [PubMed] 101. Su a anee, A.; Schae e , M.H.; Be s, M.J.; Soons, Z.; Mannspe ge , H.; Ha de , N.; Oswald, M.; Gipp, M.; Ramminge , E.; Ma cus, G.; e al. Cha ac e izing p o ein in e ac ions employing a genome-wide si na cellula pheno yping sc een. PLoS Compu . Biol. 2014,10, e1003814. [C ossRe ] [PubMed] 102. B agoszewski, P.; Go nicka, A.; Sz olsz ene , M.E.; Chacinska, A. The ubiqui in-p o easome sys em egula es mi ochond ial in e memb ane space p o eins. Mol. Cell. Biol. 2013,33, 2136–2148. [C ossRe ] [PubMed] 103. B agoszewski, P.; Tu ek, M.; Chacinska, A. Con ol o mi ochond ial biogenesis and unc ion by he ubiqui in-p o easome sys em. Open Biol. 2017,7, 170007. [C ossRe ] [PubMed] 104. Cook, C.; Pe ucelli, L. A c i ical e alua ion o he ubiqui in-p o easome sys em in Pa kinson’s disease. Biochim. Biophys. Ac a 2009,1792, 664–675. [C ossRe ] [PubMed] 105. Hwang, O. Role o oxida i e s ess in Pa kinson’s disease. Exp. Neu obiol. 2013 ,22, 11–17. [C ossRe ] [PubMed] 106. Danielson, S.R.; Ande sen, J.K. Oxida i e and ni a i e p o ein modi ica ions in Pa kinson’s disease. F ee Radic. Biol. Med. 2008,44, 1787–1794. [C ossRe ] [PubMed] 107. F iedman, J.R.; Lackne , L.L.; Wes , M.; DiBenede o, J.R.; Nunna i, J.; Voel z, G.K. ER ubules ma k si es o mi ochond ial di ision. Science 2011,334, 358–362. [C ossRe ] [PubMed] 108. Ca elli, D.; Casag ande, F.; Busce i, C.L.; Bucci, D.; Molina o, G.; T a ican e, A.; Passa ella, D.; Gia ini, E.; Pezzoli, G.; Ba aglia, G.; e al. Mic o ubule al e a ions occu ea ly in expe imen al Pa kinsonism and he mic o ubule s abilize epo hilone D is neu op o ec i e. Sci. Rep. 2013,3, 1837. [C ossRe ] [PubMed] 109. Jensen, R.E. Con ol o mi ochond ial shape. Cu . Opin. Cell Biol. 2005,17, 384–388. [C ossRe ] [PubMed] 110. Bleie , L.; D ose, S. Supe oxide gene a ion by complex III: F om mechanis ic a ionales o unc ional consequences. Biochim. Biophys. Ac a 2013,1827, 1320–1331. [C ossRe ] [PubMed] 111. Mulle , F.L.; Liu, Y.; Van Remmen, H. Complex III eleases supe oxide o bo h sides o he inne mi ochond ial memb ane. J. Biol. Chem. 2004,279, 49064–49073. [C ossRe ] [PubMed] 112. Ca elli, D.; Goldwu m, S.; Casag ande, F.; Pezzoli, G.; Cappelle i, G. Mic o ubule des abiliza ion is sha ed by gene ic and idiopa hic Pa kinson’s disease pa ien ib oblas s. PLoS ONE 2012,7, e37467. [C ossRe ] 113. Passmo e, J.B.; Pinho, S.; Gomez-Laza o, M.; Sch ade , M. The espi a o y chain inhibi o o enone a ec s pe oxisomal dynamics ia i s mic o ubule-des abilising ac i i y. His ochem. Cell Biol. 2017 ,148, 331–341. [C ossRe ] [PubMed] 114. Bindea, G.; Mlecnik, B.; Hackl, H.; Cha oen ong, P.; Tosolini, M.; Ki ilo sky, A.; F idman, W.H.; Pages, F.; T ajanoski, Z.; Galon, J. ClueGo: A cy oscape plug-in o deciphe unc ionally g ouped gene on ology and pa hway anno a ion ne wo ks. Bioin o ma ics 2009,25, 1091–1093. [C ossRe ] [PubMed] 115. Tieu, K.; Ischi opoulos, H.; P zedbo ski, S. Ni ic oxide and eac i e oxygen species in Pa kinson’s disease. IUBMB Li e 2003,55, 329–335. [C ossRe ] [PubMed] 116. Wei, T.; Chen, C.; Hou, J.; Xin, W.; Mo i, A. Ni ic oxide induces oxida i e s ess and apop osis in neu onal cells. Biochim. Biophys. Ac a 2000,1498, 72–79. [C ossRe ] 117. Pie ini, D.; B yan, N.S. Ni ic oxide a ailabili y as a ma ke o oxida i e s ess. Me hods Mol. Biol. 2015 ,1208, 63–71. [PubMed] 118. Smeyne, M.; Smeyne, R.J. Glu a hione me abolism and Pa kinson’s disease. F ee Radic. Biol. Med. 2013 ,62, 13–25. [C ossRe ] [PubMed] 119. Ba aiba , M.A.; Liu, L.; Ahmed, E.K.; F igue , B. P o ein oxida i e damage a he c oss oads o cellula senescence, aging, and age- ela ed diseases. Oxid. Med. Cell. Longe . 2012 ,2012, 919832. [C ossRe ] [PubMed] 120. Dasgup a, A.; Zheng, J.; Bizzoze o, O.A. P o ein ca bonyla ion and agg ega ion p ecede neu onal apop osis induced by pa ial glu a hione deple ion. ASN Neu o 2012,4, e00084. [C ossRe ] [PubMed]